{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:59:01Z","timestamp":1795053541846,"version":"4.10.2"},"reference-count":1002,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jtos.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T11:56:54Z","timestamp":1500551814000},"page":"575-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1329,"title":["TFOS DEWS II Management and Therapy Report"],"prefix":"10.1016","volume":"15","author":[{"given":"Lyndon","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Downie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Korb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Benitez-del-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie X.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham N.","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Geerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Yudi","family":"Hida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2598-0936","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Yul","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tais H.","family":"Wakamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Wolffsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer P.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib1","first-page":"163","article-title":"Management and therapy of dry eye disease: report of the management and therapy subcommittee of the international dry eye WorkShop","volume":"2007","year":"2007","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib2","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","article-title":"The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee","volume":"52","author":"Nelson","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/ICO.0b013e318225415a","volume":"31","author":"Lemp","year":"2012","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/ICL.0000000000000020","article-title":"Perceptions of dry eye disease management in current clinical practice","volume":"40","author":"Williamson","year":"2014","journal-title":"Eye Contact Lens"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3341\/kjo.2014.28.2.115","article-title":"Current practice pattern for dry eye patients in South Korea: a multicenter study","volume":"28","author":"Song","year":"2014","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12886-015-0122-z","article-title":"Expert opinion in the management of aqueous deficient dry eye disease (DED)","volume":"15","author":"Sy","year":"2015","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/OPX.0000000000000087","article-title":"An evidence-based analysis of Australian optometrists' dry eye practices","volume":"90","author":"Downie","year":"2013","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/opo.12280","article-title":"Comparing self-reported optometric dry eye clinical practices in Australia and the United Kingdom: is there scope for practice improvement?","volume":"36","author":"Downie","year":"2016","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.jtos.2017.05.006_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2017.05.006_bib11","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/ICO.0b013e318269cb99","article-title":"Choice of artificial tear formulation for patients with dry eye: where do we start?","volume":"31","author":"Tong","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/978-1-4615-5359-5_99","article-title":"Classification of artificial tears. I: composition and properties","volume":"438","author":"Murube","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtos.2017.05.006_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/978-1-4615-5359-5_100","article-title":"Classification of artificial tears. II: additives and commercial formulas","volume":"438","author":"Murube","year":"1998","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib14","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1517\/13543784.2013.838557","article-title":"Changing trends in the treatment of dry-eye disease","volume":"22","author":"Dogru","year":"2013","journal-title":"Expert Opin Invest Drugs"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14656566.2010.518612","article-title":"Pharmacotherapy of dry eye","volume":"12","author":"Dogru","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jtos.2017.05.006_bib16","first-page":"CD009729","article-title":"Over the counter (OTC) artificial tear drops for dry eye syndrome","volume":"2","author":"Pucker","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/OPX.0000000000000721","article-title":"A pragmatic approach to dry eye diagnosis: evidence into practice","volume":"92","author":"Downie","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1089\/jop.2014.0157","article-title":"Effect of viscous agents on corneal density in dry eye disease","volume":"31","author":"Wegener","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2017.05.006_bib19","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1167\/iovs.12-11181","article-title":"Sodium hyaluronate decreases ocular surface toxicity induced by benzalkonium chloride-preserved latanoprost: an in vivo study","volume":"54","author":"Yu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1475-1313.2009.00683.x","article-title":"Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic review","volume":"29","author":"Doughty","year":"2009","journal-title":"Ophthalmic Physiol Opt"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3144\/expresspolymlett.2008.90","article-title":"Pharmaceutical significance of cellulose: a review","volume":"2","author":"Kamel","year":"2008","journal-title":"Express Polym Lett"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib22","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1167\/iovs.06-0848","article-title":"Carboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healing","volume":"48","author":"Garrett","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/02713680802140213","article-title":"Carboxymethyl cellulose stimulates rabbit corneal epithelial wound healing","volume":"33","author":"Garrett","year":"2008","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib24","first-page":"85","article-title":"Efficacy of sodium carboxymethylcellulose in the treatment of dry eye syndrome","volume":"81","author":"Bruix","year":"2006","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/01.icl.0000181819.63425.a6","article-title":"Comparison of initial treatment response to two enhanced-viscosity artificial tears","volume":"32","author":"Noecker","year":"2006","journal-title":"Eye Contact Lens"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ICO.0b013e3181e9adcc","article-title":"Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease","volume":"30","author":"Lee","year":"2011","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.optm.2010.08.003","article-title":"A review of hyaluronan and its ophthalmic applications","volume":"82","author":"Rah","year":"2011","journal-title":"Optometry"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib28","first-page":"2313","article-title":"The effect of hyaluronic acid on corneal epithelial cell proliferation","volume":"34","author":"Inoue","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/eye.1998.213","article-title":"A comparison of the effect of hyaluronic acid versus gentamicin on corneal epithelial healing","volume":"12","author":"Stiebel-Kalish","year":"1998","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/bjo.2003.027573","article-title":"Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro","volume":"88","author":"Gomes","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1089\/jop.2004.20.548","article-title":"Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect","volume":"20","author":"Camillieri","year":"2004","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1463-5224.2010.00771.x","article-title":"A cross-linked hyaluronan gel accelerates healing of corneal epithelial abrasion and alkali burn injuries in rabbits","volume":"13","author":"Yang","year":"2010","journal-title":"Vet Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/cxo.12073","article-title":"Enhanced corneal wound healing with hyaluronic acid and high-potassium artificial tears","volume":"96","author":"Ho","year":"2013","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.jtos.2017.05.006_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0927-7757(95)03097-W","article-title":"Non-Newtonian properties of hyaluronic acid aqueous solution","volume":"97","author":"Pis\u00e1r\u010dik","year":"1995","journal-title":"Colloids Surf A"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/OPX.0b013e318182476c","article-title":"Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment","volume":"85","author":"Johnson","year":"2008","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/OPX.0000000000000101","article-title":"Effects of sodium hyaluronate on wavefront aberrations in dry eye patients","volume":"91","author":"Lekhanont","year":"2014","journal-title":"Optom Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib37","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ophtha.2012.12.022","article-title":"A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye","volume":"120","author":"Kinoshita","year":"2013","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib38","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/bjophthalmol-2011-301448","article-title":"A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients","volume":"96","author":"Takamura","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"3\u20134","key":"10.1016\/j.jtos.2017.05.006_bib39","first-page":"14","article-title":"Sodium hyaluronate eye drops in the treatment of dry eye disease: an open label, uncontrolled, multi-centre trial","volume":"24","author":"Cheema","year":"2012","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5301\/ejo.5000117","article-title":"Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease","volume":"22","author":"Baudouin","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/ICL.0000000000000236","article-title":"Efficacy and safety of 0.2% hyaluronic acid in the management of dry eye disease","volume":"43","author":"Pinto-Fraga","year":"2017","journal-title":"Eye Contact Lens"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/jop.2016.0086","article-title":"A randomized multicenter Study comparing 0.1%, 0.15%, and 0.3% sodium hyaluronate with 0.05% cyclosporine in the treatment of dry eye","volume":"33","author":"Park","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/jop.2015.0042","article-title":"Evaluation of a novel artificial tear in the prevention and treatment of dry eye in an animal model","volume":"31","author":"She","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2017.05.006_bib44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/OPTH.S78184","article-title":"Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial","volume":"9","author":"Simmons","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000315027","article-title":"Novel ocular lubricant containing an intelligent delivery system: details of its mechanism of action","volume":"45","author":"Springs","year":"2010","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib46","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2147\/OPTH.S13773","article-title":"Systane lubricant eye drops in the management of ocular dryness","volume":"5","author":"Benelli","year":"2011","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib47","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s12325-008-0112-0","article-title":"Corneal staining reductions observed after treatment with Systane lubricant eye drops","volume":"25","author":"Christensen","year":"2008","journal-title":"Adv Ther"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib48","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/ICO.0b013e3180de1c38","article-title":"An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops","volume":"26","author":"Ousler","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib49","first-page":"327","article-title":"Reduction of corneal permeability in patients treated with HP-guar: a fluorophotometric study","volume":"81","author":"Cervan-Lopez","year":"2006","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib50","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/ICO.0b013e3181ca636b","article-title":"The impact of artificial tears containing hydroxypropyl guar on mucous layer","volume":"29","author":"Moon","year":"2010","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/ICL.0b013e31818c66b5","article-title":"Impact on ocular surface evaporation of an artificial tear solution containing hydroxypropyl guar","volume":"34","author":"Uchiyama","year":"2008","journal-title":"Eye Contact Lens"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib52","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/eye.2010.24","article-title":"The effect of preservative-free HP-Guar on dry eye after phacoemulsification: a flow cytometric study","volume":"24","author":"S\u00e1nchez","year":"2010","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clae.2005.12.003","article-title":"A clinical evaluation of Systane","volume":"29","author":"Gifford","year":"2006","journal-title":"Cont Lens Anter Eye"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib54","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/jop.2014.0164","article-title":"Effects of a hyaluronic acid\/hydroxypropyl guar artificial tear solution on protection, recovery, and lubricity in models of corneal epithelium","volume":"31","author":"Rangarajan","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib55","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0161-6420(81)35074-X","article-title":"The use of slow-release artificial tears in the long-term management of keratitis sicca","volume":"88","author":"Werblin","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2017.05.006_bib56","first-page":"214","article-title":"Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life","volume":"107","author":"McDonald","year":"2009","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib57","first-page":"75","article-title":"The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye WorkShop","volume":"2007","year":"2007","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib58","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0002-9394(89)90657-0","article-title":"Ophthalmic solutions, the ocular surface, and a unique therapeutic artificial tear formulation","volume":"107","author":"Gilbard","year":"1989","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib59","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0161-6420(92)31929-3","article-title":"An electrolyte-based solution that increases corneal glycogen and conjunctival goblet-cell density in a rabbit model for keratoconjunctivitis sicca","volume":"99","author":"Gilbard","year":"1992","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib60","first-page":"141","article-title":"Dry eye: pharmacological approaches, effects, and progress","volume":"22","author":"Gilbard","year":"1996","journal-title":"CLAO J"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib61","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/ICO.0b013e318180e55c","article-title":"Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study","volume":"27","author":"Troiano","year":"2008","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jfo.2011.07.017","article-title":"Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease","volume":"35","author":"Baeyens","year":"2012","journal-title":"J Fr Ophtalmol"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib63","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/ICO.0b013e318242fd60","article-title":"Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management","volume":"31","author":"Sullivan","year":"2012","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcjo.2012.08.019","article-title":"Effects of phytoestrogen supplementation in postmenopausal women with dry eye syndrome: a randomized clinical trial","volume":"47","author":"Scuderi","year":"2012","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib65","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/02713683.2012.757323","article-title":"Effectiveness of dry eye therapy under conditions of environmental stress","volume":"38","author":"Tomlinson","year":"2013","journal-title":"Curr Eye Res"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib66","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5301\/ejo.5000267","article-title":"Discomfort symptoms reduction and ocular surface parameters recovery with Artelac Rebalance treatment in mild-moderate dry eye","volume":"23","author":"Versura","year":"2013","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib67","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/OPX.0b013e318288bdbe","article-title":"Intrasubject tear osmolarity changes with two different types of eyedrops","volume":"90","author":"Montani","year":"2013","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib68","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/bjophthalmol-2013-303742","article-title":"A randomised controlled trial comparing a thermal massager with artificial teardrops for the treatment of dry eye","volume":"98","author":"Lee","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcjo.2015.03.008","article-title":"Effects of osmoprotective eye drops on tear osmolarity in contact lens wearers","volume":"50","author":"Aslan Bayhan","year":"2015","journal-title":"Can J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib70","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/ICO.0000000000000148","article-title":"Tear film osmolarity in ocular mucous membrane pemphigoid","volume":"33","author":"Miserocchi","year":"2014","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib71","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0161-6420(89)32909-5","article-title":"Open-label crossover study of vitamin A ointment as a treatment for keratoconjunctivitis sicca","volume":"96","author":"Gilbard","year":"1989","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib72","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jtos.2013.12.001","article-title":"Evaluation of an automated thermodynamic treatment (LipiFlow\u00ae) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial","volume":"12","author":"Finis","year":"2014","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib73","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00003226-199107000-00002","article-title":"Meibomian gland morphology and tear osmolarity: changes with Accutane therapy","volume":"10","author":"Mathers","year":"1991","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib74","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/ICO.0b013e31823f8cb6","article-title":"Tear film osmolarity in patients treated for glaucoma or ocular hypertension","volume":"31","author":"Labb\u00e9","year":"2012","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib75","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3349\/ymj.2014.55.1.203","article-title":"Inflammatory cytokine and osmolarity changes in the tears of dry eye patients treated with topical 1% methylprednisolone","volume":"55","author":"Lee","year":"2014","journal-title":"Yonsei Med J"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib76","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4103\/2008-322X.150803","article-title":"Topical cyclosporine a for treatment of dry eye due to chronic mustard gas injury","volume":"9","author":"Jadidi","year":"2014","journal-title":"J Ophthalmic Vis Res"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clae.2015.07.003","article-title":"Assessment of the effect of cyclosporine-A 0.05% emulsion on the ocular surface and corneal sensation following cataract surgery","volume":"39","author":"Hamada","year":"2016","journal-title":"Cont Lens Anter Eye"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib78","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archopht.1988.01060130530029","article-title":"Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca","volume":"106","author":"Nelson","year":"1988","journal-title":"Arch Ophthalmol"},{"issue":"Pt 6","key":"10.1016\/j.jtos.2017.05.006_bib79","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/eye.2000.244","article-title":"Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca","volume":"14","author":"Iester","year":"2000","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib80","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clae.2010.01.003","article-title":"Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness","volume":"33","author":"Benelli","year":"2010","journal-title":"Cont Lens Anter Eye"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib81","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3109\/02713683.2013.806670","article-title":"Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye","volume":"38","author":"C\u00f6mez","year":"2013","journal-title":"Curr Eye Res"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib82","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1167\/iovs.07-1528","article-title":"Expression and localization of carnitine\/organic cation transporter OCTN1 and OCTN2 in ocular epithelium","volume":"49","author":"Garrett","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib83","first-page":"1823","article-title":"Transport of L-carnitine in human corneal and conjunctival epithelial cells","volume":"16","author":"Xu","year":"2010","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtos.2017.05.006_bib84","first-page":"1945","article-title":"Decrease in hyperosmotic stress-induced corneal epithelial cell apoptosis by L-carnitine","volume":"19","author":"Khandekar","year":"2013","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtos.2017.05.006_bib85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.exer.2012.12.001","article-title":"Betaine stabilizes cell volume and protects against apoptosis in human corneal epithelial cells under hyperosmotic stress","volume":"108","author":"Garrett","year":"2013","journal-title":"Exp Eye Res"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib86","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/ICO.0b013e318165b19e","article-title":"Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells","volume":"27","author":"Corrales","year":"2008","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib87","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/02713683.2014.957776","article-title":"Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress","volume":"40","author":"Hua","year":"2015","journal-title":"Curr Eye Res"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib88","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1167\/iovs.13-12081","article-title":"Efficacy of osmoprotectants on prevention and treatment of murine dry eye","volume":"54","author":"Chen","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib89","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","article-title":"Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting","volume":"11","author":"Baudouin","year":"2013","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib90","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.exer.2009.03.015","article-title":"Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis","volume":"89","author":"Chen","year":"2009","journal-title":"Exp Eye Res"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib91","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3109\/02713683.2012.700754","article-title":"Evaluation of protective effects of trehalose on desiccation of epithelial cells in three dimensional reconstructed human corneal epithelium","volume":"37","author":"Hovakimyan","year":"2012","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib92","first-page":"317","article-title":"Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system","volume":"18","author":"Li","year":"2012","journal-title":"Mol Vis"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib93","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.3390\/ijms10093793","article-title":"Trehalose metabolism: from osmoprotection to signaling","volume":"10","author":"Iturriaga","year":"2009","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib94","first-page":"577","article-title":"Trehalose: an intriguing disaccharide with potential for medical application in ophthalmology","volume":"5","author":"Luyckx","year":"2011","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib95","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/bjo.85.5.610","article-title":"Trehalose protects corneal epithelial cells from death by drying","volume":"85","author":"Matsuo","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib96","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1074\/jbc.M609532200","article-title":"Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein","volume":"282","author":"Sarkar","year":"2007","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib97","first-page":"1029","article-title":"Trehalose treatment accelerates the healing of UVB-irradiated corneas. Comparative immunohistochemical studies on corneal cryostat sections and corneal impression cytology","volume":"27","author":"Cejkov\u00e1","year":"2012","journal-title":"Histol Histopathol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib98","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib99","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF00164671","article-title":"Oxidative reactions in the tear fluid of patients suffering from dry eyes","volume":"233","author":"Augustin","year":"1995","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archophthalmol.2009.52","article-title":"Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye","volume":"127","author":"Hongyok","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib101","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajo.2008.08.015","article-title":"A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome","volume":"147","author":"Kim","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib102","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","article-title":"TFOS DEWS II Iatrogenic report","volume":"15","author":"Gomes","year":"2017","journal-title":"Ocul Surf"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib103","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/jop.2013.0014","article-title":"Bioavailability of antioxidants applied to stratified human corneal epithelial cells","volume":"29","author":"Stoddard","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib104","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s12325-015-0273-6","article-title":"Results of a multicenter, randomized, double-masked, placebo-controlled clinical study of the efficacy and safety of Visomitin eye drops in patients with dry eye syndrome","volume":"32","author":"Brzheskiy","year":"2015","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/abbi.2000.1735","article-title":"Selenoprotein P: properties, functions, and regulation","volume":"376","author":"Mostert","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jtos.2017.05.006_bib106","doi-asserted-by":"crossref","first-page":"e9911","DOI":"10.1371\/journal.pone.0009911","article-title":"Selenoprotein P controls oxidative stress in cornea","volume":"5","author":"Higuchi","year":"2010","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1016\/j.jtos.2017.05.006_bib107","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S0039-6257(00)00200-9","article-title":"The pathology of dry eye","volume":"45","author":"Baudouin","year":"2001","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib108","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02853166","article-title":"Effects of common ophthalmic preservatives on ocular health","volume":"18","author":"Noecker","year":"2001","journal-title":"Adv Ther"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib109","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/02713683.2011.562340","article-title":"Ocular surface disease in patients with ocular hypertension and glaucoma","volume":"36","author":"Stewart","year":"2011","journal-title":"Curr Eye Res"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib110","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/ACI.0b013e32834a95c9","article-title":"Ocular surface damage by ophthalmic compounds","volume":"11","author":"Mantelli","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib111","doi-asserted-by":"crossref","first-page":"518","DOI":"10.5301\/ejo.5000270","article-title":"Preservative-free treatment in glaucoma: who, when, and why","volume":"23","author":"Stalmans","year":"2013","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib112","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/ICU.0b013e32835c8aba","article-title":"Glaucoma therapy and ocular surface disease: current literature and recommendations","volume":"24","author":"Anwar","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib113","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/IJG.0000000000000279","article-title":"The impact of glaucoma medications on corneal wound healing","volume":"25","author":"Pinheiro","year":"2016","journal-title":"J Glaucoma"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib114","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/ICO.0b013e3182a8196f","article-title":"Changes in rabbit corneal innervation induced by the topical application of benzalkonium chloride","volume":"32","author":"Chen","year":"2013","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib115","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1167\/iovs.12-10725","article-title":"A mouse model of limbal stem cell deficiency induced by topical medication with the preservative benzalkonium chloride","volume":"54","author":"Lin","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib116","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1076\/orbi.18.2.89.2717","article-title":"How the most common preservative affects the Meibomian lipid layer","volume":"18","author":"Kaercher","year":"1999","journal-title":"Orbit"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib117","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00417-012-1999-3","article-title":"The Ex Vivo Eye Irritation Test (EVEIT) in evaluation of artificial tears: Purite-preserved versus unpreserved eye drops","volume":"250","author":"Schrage","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib118","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1167\/iovs.14-14483","article-title":"Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops","volume":"55","author":"Jee","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib119","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/bjo.2005.082792","article-title":"Corneal calcification following intensified treatment with sodium hyaluronate artificial tears","volume":"90","author":"Bernauer","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/ICL.0b013e3181faa43e","article-title":"Effects of multipurpose contact lens care solutions and their ingredients on membrane-associated mucins of human corneal epithelial cells","volume":"36","author":"Imayasu","year":"2010","journal-title":"Eye Contact Lens"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2017.05.006_bib121","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.clae.2010.06.010","article-title":"Nonclinical safety evaluation of boric acid and a novel borate-buffered contact lens multi-purpose solution, Biotrue multi-purpose solution","volume":"33","author":"Lehmann","year":"2010","journal-title":"Cont Lens Anter Eye"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib122","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1021\/la803095q","article-title":"Reversible flocculation with hydroxypropyl guar-borate, a labile anionic polyelectrolyte","volume":"25","author":"Pelton","year":"2009","journal-title":"Langmuir"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib123","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1021\/bm100655j","article-title":"Cationic liposome colloidal stability in the presence of guar derivatives suggests depletion interactions may be operative in artificial tears","volume":"11","author":"Khanal","year":"2010","journal-title":"Biomacromolecules"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib124","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1023\/A:1011956327987","article-title":"Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line","volume":"15","author":"Saarinen-Savolainen","year":"1998","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jfo.2015.09.011","article-title":"Long-term tolerance of preservative-free eye drops containing macrogol hydroxystearate as an excipient","volume":"39","author":"Viaud-Quentric","year":"2016","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib126","first-page":"175","article-title":"Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells","volume":"2","author":"Smedowski","year":"2014","journal-title":"J Biochem Pharmacol Res"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib127","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/jop.2011.0053","article-title":"Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops","volume":"28","author":"Gensheimer","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2017.05.006_bib128","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II Tear Film report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul Surf"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib129","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.eye.6700566","article-title":"Tears in health and disease","volume":"17","author":"Tiffany","year":"2003","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1444-0938.2011.00634.x","article-title":"Osmolality and tear film dynamics","volume":"95","author":"Stahl","year":"2012","journal-title":"Clin Exp Optom"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib131","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.exer.2011.09.005","article-title":"Stratified corneal limbal epithelial cells are protected from UVB-induced apoptosis by elevated extracellular K\u207a","volume":"93","author":"Schotanus","year":"2011","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib132","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.exer.2009.10.005","article-title":"Inhibition of UV-B induced apoptosis in corneal epithelial cells by potassium channel modulators","volume":"90","author":"Ubels","year":"2010","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib133","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000267153","article-title":"Tear potassium contributes to maintenance of corneal thickness","volume":"24","author":"Green","year":"1992","journal-title":"Ophthalmic Res"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib134","first-page":"1484","article-title":"Essential ions for maintenance of the corneal epithelial surface","volume":"26","author":"Bachman","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib135","series-title":"Smolin and Thoft's The Cornea: Scientific Foundations and Clinical Practice","author":"Smolin","year":"2005"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib136","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00003226-199303000-00004","article-title":"Artificial tear composition and promotion of recovery of the damaged corneal epithelium","volume":"12","author":"Lopez Bernal","year":"1993","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib137","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archopht.1995.01100030127036","article-title":"Effects of preservative-free artificial tear solutions on corneal epithelial structure and function","volume":"113","author":"Ubels","year":"1995","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib138","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00006324-199701000-00014","article-title":"Importance of the lipid layer in human tear film stability and evaporation","volume":"74","author":"Craig","year":"1997","journal-title":"Optom Vis Sci"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib139","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/OPX.0b013e31826f32e0","article-title":"Lipid-containing lubricants for dry eye: a systematic review","volume":"89","author":"Lee","year":"2012","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib140","first-page":"1419","article-title":"Artificial tears potpourri: a literature review","volume":"8","author":"Moshirfar","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib141","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/01.opx.0000171818.01353.8c","article-title":"The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms","volume":"82","author":"Korb","year":"2005","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib142","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.icl.0000247638.50568.c0","article-title":"Comparison of the efficacy of two lipid emulsion eyedrops in increasing tear film lipid layer thickness","volume":"33","author":"Scaffidi","year":"2007","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2017.05.006_bib143","doi-asserted-by":"crossref","first-page":"R635","DOI":"10.1088\/0953-8984\/18\/41\/R01","article-title":"Nanoemulsions: formation, structure, and physical properties","volume":"18","author":"Mason","year":"2006","journal-title":"J Phys Condens Matter"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib144","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10719-008-9136-6","article-title":"Glycan structures of ocular surface mucins in man, rabbit and dog display species differences","volume":"25","author":"Royle","year":"2008","journal-title":"Glycoconj J"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jphp.12075","article-title":"Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery","volume":"66","author":"Daull","year":"2014","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib146","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jfo.2014.05.001","article-title":"Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - a randomised comparative study","volume":"37","author":"Amrane","year":"2014","journal-title":"J Fr Ophtalmol"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib147","doi-asserted-by":"crossref","first-page":"125101","DOI":"10.1088\/0957-4484\/25\/12\/125101","article-title":"A novel nanoscale-dispersed eye ointment for the treatment of dry eye disease","volume":"25","author":"Zhang","year":"2014","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jtos.2017.05.006_bib148","doi-asserted-by":"crossref","first-page":"604204","DOI":"10.1155\/2012\/604204","article-title":"Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb","volume":"2012","author":"Lallemand","year":"2012","journal-title":"J Drug Deliv"},{"key":"10.1016\/j.jtos.2017.05.006_bib149","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.exer.2014.01.006","article-title":"Cationorm shows good tolerability on human HCE-2 corneal epithelial cell cultures","volume":"120","author":"Kinnunen","year":"2014","journal-title":"Exp Eye Res"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5301\/ejo.5000593","article-title":"Comparison of the lubricant eyedrops Optive\u00ae, Vismed Multi\u00ae, and Cationorm\u00ae on the corneal healing process in an ex vivo model","volume":"25","author":"Pinheiro","year":"2015","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib151","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/10837450903479954","article-title":"Development of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular application","volume":"16","author":"Yoncheva","year":"2011","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib152","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1517\/17425240902762818","article-title":"Chitosan nanoparticles for drug delivery to the eye","volume":"6","author":"Paolicelli","year":"2009","journal-title":"Expert Opin Drug Deliv"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2017.05.006_bib153","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00760-8","article-title":"Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A","volume":"224","author":"De Campos","year":"2001","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib154","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000310154","article-title":"Lipid-containing eye drops: a step closer to natural tears","volume":"201","author":"Rieger","year":"1990","journal-title":"Ophthalmologica"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3341\/kjo.2015.29.2.131","article-title":"Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye","volume":"29","author":"Choi","year":"2015","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib156","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/10837450.2013.769569","article-title":"Castor oil and mineral oil nanoemulsion: development and compatibility with a soft contact lens","volume":"19","author":"Katzer","year":"2014","journal-title":"Pharm Dev Technol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib157","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clae.2009.10.005","article-title":"Effect of castor oil emulsion eyedrops on tear film composition and stability","volume":"33","author":"Ma\u00efssa","year":"2010","journal-title":"Cont Lens Anter Eye"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib158","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/ICO.0b013e31823f8c9b","article-title":"Clinical treatment of dry eye using 0.03% tacrolimus eye drops","volume":"31","author":"Moscovici","year":"2012","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib159","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1167\/iovs.12-10487","article-title":"Do lipids retard the evaporation of the tear fluid?","volume":"53","author":"Rantam\u00e4ki","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5935\/0004-2749.20150078","article-title":"Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits","volume":"78","author":"Parrilha","year":"2015","journal-title":"Arq Bras Oftalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib161","first-page":"465","article-title":"Microemulsions as potential ocular drug delivery systems: phase diagrams and physical properties depending on ingredients","volume":"62","author":"Radomska-Soukharev","year":"2005","journal-title":"Acta Pol Pharm"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib162","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000267872","article-title":"Phospholipids in meibomian gland secretion","volume":"28","author":"Greiner","year":"1996","journal-title":"Ophthalmic Res"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib163","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1167\/iovs.11-9419","article-title":"Mass spectrometric identification of phospholipids in human tears and tear lipocalin","volume":"53","author":"Dean","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib164","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1167\/iovs.05-0756","article-title":"Identification and comparison of the polar phospholipids in normal and dry eye rabbit tears by MALDI-TOF mass spectrometry","volume":"47","author":"Ham","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib165","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archopht.116.7.849","article-title":"Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality","volume":"116","author":"Shine","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib166","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1167\/iovs.10-5687","article-title":"Shotgun lipidomic analysis of human meibomian gland secretions with electrospray ionization tandem mass spectrometry","volume":"51","author":"Chen","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib167","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11745-007-3080-2","article-title":"Liquid chromatography-mass spectrometric analysis of lipids present in human meibomian gland secretions","volume":"42","author":"Butovich","year":"2007","journal-title":"Lipids"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib168","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1194\/jlr.M900252-JLR200","article-title":"Human tear film and meibum. Very long chain wax esters and (O-acyl)-omega-hydroxy fatty acids of meibum","volume":"50","author":"Butovich","year":"2009","journal-title":"J Lipid Res"},{"issue":"14","key":"10.1016\/j.jtos.2017.05.006_bib169","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1021\/ac058000a","article-title":"MALDI-TOF MS of phosphorylated lipids in biological fluids using immobilized metal affinity chromatography and a solid ionic crystal matrix","volume":"77","author":"Ham","year":"2005","journal-title":"Anal Chem"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib170","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exer.2010.12.012","article-title":"Identification of phospholipids in human meibum by nano-electrospray ionisation tandem mass spectrometry","volume":"92","author":"Saville","year":"2011","journal-title":"Exp Eye Res"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib171","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/jms.725","article-title":"Identification, quantification and comparison of major non-polar lipids in normal and dry eye tear lipidomes by electrospray tandem mass spectrometry","volume":"39","author":"Ham","year":"2004","journal-title":"J Mass Spectrom"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib172","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtos.2014.06.002","article-title":"The presence and significance of polar meibum and tear lipids","volume":"13","author":"Pucker","year":"2015","journal-title":"Ocul Surf"},{"issue":"Pt A","key":"10.1016\/j.jtos.2017.05.006_bib173","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/978-1-4615-0717-8_69","article-title":"The effects of anionic and zwitterionic phospholipids on the tear film lipid layer","volume":"506","author":"Korb","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtos.2017.05.006_bib174","first-page":"38","article-title":"Are phospholipids the critical ingredient?","volume":"149","author":"Korb","year":"2012","journal-title":"Rev Cornea Contact Lens"},{"key":"10.1016\/j.jtos.2017.05.006_bib175","series-title":"The Preocular Tear Film in Health, Disease, and Contact Lens Wear","first-page":"570","article-title":"Recent findings on the chemical composition of steer and human meibomian glands","author":"Nicolaides","year":"1986"},{"key":"10.1016\/j.jtos.2017.05.006_bib176","first-page":"79","article-title":"A compositional based model for the tear film lipid layer","volume":"95","author":"McCulley","year":"1997","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib177","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/112067210701700202","article-title":"A comparison of the effect of carbomer-, cellulose- and mineral oil-based artificial tear formulations","volume":"17","author":"Wang","year":"2007","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib178","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clae.2009.12.007","article-title":"Effect of a liposomal spray on the pre-ocular tear film","volume":"33","author":"Craig","year":"2010","journal-title":"Cont Lens Anter Eye"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib179","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clinthera.2010.01.024","article-title":"Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study","volume":"32","author":"Wang","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.jtos.2017.05.006_bib180","article-title":"Effect of three different liposomal eye sprays on ocular comfort and tear film","volume":"35","author":"Pult","year":"2012","journal-title":"Cont Lens Anter Eye"},{"key":"10.1016\/j.jtos.2017.05.006_bib181","doi-asserted-by":"crossref","first-page":"135987","DOI":"10.1155\/2015\/135987","article-title":"A pilot study: the efficacy of virgin coconut oil as ocular rewetting agent on rabbit eyes","volume":"2015","author":"Mutalib","year":"2015","journal-title":"Evid Based Complement Altern Med"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib182","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.clinthera.2015.01.001","article-title":"Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial","volume":"37","author":"Simmons","year":"2015","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib183","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archopht.1975.01010020815015","article-title":"Clinical experience with a mobile ocular perfusion pump","volume":"93","author":"Ralph","year":"1975","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib184","doi-asserted-by":"crossref","first-page":"826970","DOI":"10.1155\/2014\/826970","article-title":"Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies","volume":"2014","author":"Semeraro","year":"2014","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib185","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sj\u00f6gren's syndrome","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib186","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/ICO.0000000000000147","article-title":"Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sj\u00f6gren syndrome","volume":"33","author":"Hwang","year":"2014","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib187","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/02713683.2014.1002051","article-title":"Autologous serum eye drops accelerate epithelial healing after LASEK","volume":"41","author":"Hondur","year":"2016","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib188","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2147\/OPTH.S33427","article-title":"Conservative treatment for late-onset bleb leaks after trabeculectomy with mitomycin C in patients with ocular surface disease","volume":"6","author":"Sagara","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib189","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1442-9071.2010.02304.x","article-title":"Long-term follow up of autologous serum treatment for recurrent corneal erosions","volume":"38","author":"Ziakas","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib190","first-page":"948","article-title":"Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells","volume":"42","author":"Geerling","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib191","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/ICO.0000000000000109","article-title":"Corneal wound healing promoted by 3 blood derivatives: an in vitro and in vivo comparative study","volume":"33","author":"Freire","year":"2014","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib192","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/01.ico.0000208817.40237.8c","article-title":"Effects of autologous serum eye drops on corneal wound healing after superficial keratectomy in rabbits","volume":"25","author":"Akyol-Salman","year":"2006","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib193","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.0041-1132.2004.04079.x","article-title":"Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects?","volume":"44","author":"Hartwig","year":"2004","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib194","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.0958-7578.2005.00559.x","article-title":"Topical treatment of ocular surface defects: comparison of the epitheliotrophic capacity of fresh frozen plasma and serum on corneal epithelial cells in an in vitro cell culture model","volume":"15","author":"Hartwig","year":"2005","journal-title":"Transfus Med"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib195","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/01.ico.0000160967.65953.ea","article-title":"Use of autologous serum in corneal epithelial defects post-lamellar surgery","volume":"24","author":"Esquenazi","year":"2005","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib196","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/ICO.0000000000000726","article-title":"Effects of autologous serum eye drops on conjunctival expression of MUC5AC in patients with ocular surface disorders","volume":"35","author":"L\u00f3pez-Garc\u00eda","year":"2016","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib197","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/02713680802254790","article-title":"The effect of therapeutic human serum drops on corneal stromal wound-healing activity","volume":"33","author":"Watson","year":"2008","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib198","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2008-1027199","article-title":"Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis","volume":"225","author":"Harloff","year":"2008","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.jtos.2017.05.006_bib199","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00347-008-1753-8","article-title":"Experiences with a centralised national service for autologous serum eyedrops in England","volume":"105","author":"Maclennan","year":"2008","journal-title":"Ophthalmologe"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib200","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","article-title":"Autologous serum eye drops for ocular surface disorders","volume":"88","author":"Geerling","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib201","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00347-008-1751-x","article-title":"Legal regulations to produce serum eye drops : when is it necessary, and how can it be obtained?","volume":"105","author":"Geerling","year":"2008","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.jtos.2017.05.006_bib202","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00347-008-1692-4","article-title":"Manufacture of autologous serum eye drops for out-patient therapy : cooperation between ophthalmic clinic and transfusion medicine department","volume":"105","author":"Dietrich","year":"2008","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.jtos.2017.05.006_bib203","first-page":"998","article-title":"Epitheliotrophic capacity of serum and plasma eyedrops. Influence of centrifugation","volume":"101","author":"Herminghaus","year":"2004","journal-title":"Ophthalmologe"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib204","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00417-004-1106-5","article-title":"An optimised protocol for the production of autologous serum eyedrops","volume":"243","author":"Liu","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-3148.2011.01072.x","article-title":"Low-cost protocol for the production of autologous serum eye drops by blood collection and processing centres for the treatment of ocular surface diseases","volume":"21","author":"Partal","year":"2011","journal-title":"Transfus Med"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib206","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/ICO.0b013e318186321e","article-title":"Time- and temperature-dependent stability of growth factor peptides in human autologous serum eye drops","volume":"28","author":"Bradley","year":"2009","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib207","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/ICO.0b013e3182542085","article-title":"Stability of serum eye drops after storage of 6 months","volume":"31","author":"Fischer","year":"2012","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib208","first-page":"292","article-title":"Stability of growth factors in autologous serum eyedrops after long-term storage","volume":"41","author":"L\u00f3pez-Garc\u00eda","year":"2016","journal-title":"Curr Eye Res"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib209","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/02713683.2013.855237","article-title":"Comparison of application systems for autologous serum eye drops","volume":"39","author":"Spaniol","year":"2014","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib210","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00347-008-1776-1","article-title":"On the use of autologous serum eyedrops in Germany : results of a survey among members of the Cornea Section of the German Ophthalmological Society (DOG)","volume":"105","author":"Kasper","year":"2008","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.jtos.2017.05.006_bib211","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archophthalmol.2012.1652","article-title":"Use of autologous serum eyedrops for the treatment of ocular surface disease: first US experience in a large population as an insurance-covered benefit","volume":"130","author":"Dalmon","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib212","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.transci.2015.11.011","article-title":"Sustained benefits of autologous serum eye drops on self-reported ocular symptoms and vision-related quality of life in Australian patients with dry eye and corneal epithelial defects","volume":"53","author":"Mondy","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib213","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bjo.2003.026211","article-title":"Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease","volume":"88","author":"Noble","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib214","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","article-title":"The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study","volume":"139","author":"Kojima","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3928\/1081-597X-20060101-13","article-title":"Autologous serum eye drops for dry eye after LASIK","volume":"22","author":"Noda-Tsuruya","year":"2006","journal-title":"J Refract Surg"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib216","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2007.03.016","article-title":"Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome","volume":"144","author":"Yoon","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib217","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3109\/02713683.2012.674609","article-title":"Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome","volume":"37","author":"Urzua","year":"2012","journal-title":"Curr Eye Res"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib218","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00417-014-2599-1","article-title":"The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study","volume":"252","author":"Celebi","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib219","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ICO.0000000000000271","article-title":"Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease","volume":"33","author":"Hussain","year":"2014","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/02713683.2013.824987","article-title":"The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment","volume":"39","author":"Jirsova","year":"2014","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib221","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1111\/aos.12167","article-title":"Autologous serum eye drops diluted with sodium hyaluronate: clinical and experimental comparative study","volume":"92","author":"L\u00f3pez-Garc\u00eda","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib222","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jtos.2015.01.005","article-title":"Autologous serum tears for treatment of photoallodynia in patients with corneal neuropathy: efficacy and evaluation with in vivo confocal microscopy","volume":"13","author":"Aggarwal","year":"2015","journal-title":"Ocul Surf"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib223","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/ICO.0000000000000515","article-title":"Comparative evaluation of silicone hydrogel contact lenses and autologous serum for management of sj\u00f6gren syndrome-associated dry eye","volume":"34","author":"Li","year":"2015","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib224","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/bjophthalmol-2013-304801","article-title":"Comparative role of 20% cord blood serum and 20% autologous serum in dry eye associated with Hansen's disease: a tear proteomic study","volume":"99","author":"Mukhopadhyay","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/08820538.2013.768678","article-title":"A comparison of the efficacy of autologous serum eye drops with amniotic membrane transplantation in neurotrophic keratitis","volume":"29","author":"Turkoglu","year":"2014","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib226","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.bmt.1705426","article-title":"Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation","volume":"38","author":"Leite","year":"2006","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib227","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/ICO.0b013e3182910036","article-title":"Contamination risk of 100% autologous serum eye drops in management of ocular surface diseases","volume":"32","author":"Thanathanee","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib228","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/OPTH.S15847","article-title":"Fulminant bilateral Haemophilus influenzae keratitis in a patient with hypovitaminosis A treated with contaminated autologous serum","volume":"5","author":"Sanz-Marco","year":"2011","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib229","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/eye.2013.102","article-title":"Autologous plasma eyedrops prepared in a closed system: a treatment for dry eye","volume":"27","author":"Petznick","year":"2013","journal-title":"Eye (Lond)"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib230","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/ICO.0b013e3180645cd7","article-title":"Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease","volume":"26","author":"Chiang","year":"2007","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib231","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/jop.2012.0002","article-title":"Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease","volume":"28","author":"Na","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib232","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/aos.12386","article-title":"Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy","volume":"92","author":"Harritsh\u00f8j","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib233","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bjophthalmol-2012-301668","article-title":"Allogeneic serum eye drops: time these became the norm?","volume":"96","author":"Badami","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib234","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4068\/cmj.2014.50.3.82","article-title":"Use of umbilical cord serum in ophthalmology","volume":"50","author":"Yoon","year":"2014","journal-title":"Chonnam Med J"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib235","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.ico.0000183484.85636.b6","article-title":"Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome","volume":"25","author":"Yoon","year":"2006","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib236","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bmt.1705566","article-title":"Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease","volume":"39","author":"Yoon","year":"2007","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib237","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1167\/iovs.05-0876","article-title":"Corneal epitheliotrophic capacity of three different blood-derived preparations","volume":"47","author":"Liu","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib238","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.bbmt.2016.05.023","article-title":"A single-center pilot prospective study of topical application of platelet-derived eye drops for patients with ocular chronic graft-versus-host disease","volume":"22","author":"Zallio","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.jtos.2017.05.006_bib239","doi-asserted-by":"crossref","first-page":"8406832","DOI":"10.1155\/2016\/8406832","article-title":"The effect of autologous platelet lysate eye drops: an in vivo confocal microscopy study","volume":"2016","author":"Fea","year":"2016","journal-title":"Biomed Res Int"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib240","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.oftal.2016.03.001","volume":"91","author":"Riestra","year":"2016","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib241","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.exer.2016.08.012","article-title":"PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model","volume":"151","author":"Anitua","year":"2016","journal-title":"Exp Eye Res"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib242","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000100933","article-title":"Symptomatic dry eye treatment with autologous platelet-rich plasma","volume":"39","author":"Alio","year":"2007","journal-title":"Ophthalmic Res"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib243","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/ICO.0b013e31820d86d6","article-title":"Efficacy of plasma rich in growth factors for the treatment of dry eye","volume":"30","author":"L\u00f3pez-Plandolit","year":"2011","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib244","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/bmt.2012.64","article-title":"Autologous platelet lysate for treatment of refractory ocular GVHD","volume":"47","author":"Pezzotta","year":"2012","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib245","first-page":"165","article-title":"Clinical trial of ambroxol (Mucosolvan) in Sj\u00f6gren's syndrome","volume":"13","author":"Ichikawa","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1016\/j.jtos.2017.05.006_bib246","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1550-2783-2-2-38","article-title":"The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress","volume":"2","author":"Kerksick","year":"2005","journal-title":"J Int Soc Sports Nutr"},{"key":"10.1016\/j.jtos.2017.05.006_bib247","first-page":"337","article-title":"Comparison of local acetylcysteine and artificial tears in the management of dry eye syndrome","volume":"59","author":"Pokupec","year":"2005","journal-title":"Acta Med Croat"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib248","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00006324-200306000-00007","article-title":"Management of filamentary keratitis associated with aqueous-deficient dry eye","volume":"80","author":"Albietz","year":"2003","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib249","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1167\/iovs.10-5801","article-title":"TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells","volume":"52","author":"Pan","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib250","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00418-012-0924-5","article-title":"Calcium regulation by thermo- and osmosensing transient receptor potential vanilloid channels (TRPVs) in human conjunctival epithelial cells","volume":"137","author":"Mergler","year":"2012","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.jtos.2017.05.006_bib251","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1167\/iovs.16-20303","article-title":"Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease","volume":"57","author":"Benitez-Del-Castillo","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib252","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/ICO.0b013e31823f8cfc","article-title":"Visual function changes after punctal occlusion with the treatment of short BUT type of dry eye","volume":"31","author":"Kaido","year":"2012","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib253","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1167\/iovs.09-5097","article-title":"Upper punctal occlusion versus lower punctal occlusion in dry eye","volume":"51","author":"Chen","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib254","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/ICO.0b013e31823f8d9e","article-title":"Effect of punctal occlusion on tear menisci in symptomatic contact lens wearers","volume":"31","author":"Li","year":"2012","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib255","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/ICL.0b013e31817fa604","article-title":"The impact of punctal occlusion on soft contact lens wearing comfort and the tear film","volume":"34","author":"Geldis","year":"2008","journal-title":"Eye Contact Lens"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib256","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/02713683.2013.841258","article-title":"Efficacy of punctal occlusion in management of dry eyes after laser in situ keratomileusis for myopia","volume":"39","author":"Alfawaz","year":"2014","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib257","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s10384-012-0125-8","article-title":"Punctal plugs for treatment of post-LASIK dry eye","volume":"56","author":"Yung","year":"2012","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib258","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3928\/1081597X-20080401-14","article-title":"LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment","volume":"24","author":"Ambr\u00f3sio","year":"2008","journal-title":"J Refract Surg"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib259","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bmt.2012.50","article-title":"Surgical management of lacrimal punctal cauterization in chronic GVHD-related dry eye with recurrent punctal plug extrusion","volume":"47","author":"Yaguchi","year":"2012","journal-title":"Bone Marrow Transpl"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib260","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/bmt.2011.205","article-title":"Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD","volume":"47","author":"Sabti","year":"2012","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib261","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9394(14)71647-2","article-title":"Lacrimal punctal occlusion for the treatment of superior limbic keratoconjunctivitis","volume":"124","author":"Yang","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib262","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00003226-200203000-00001","article-title":"The clinical efficacy of silicone punctal plug therapy","volume":"21","author":"Tai","year":"2002","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib263","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jtos.2015.12.004","article-title":"Effects of punctal occlusion on clinical signs and symptoms and on tear cytokine levels in patients with dry eye","volume":"14","author":"Tong","year":"2016","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib264","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0002-9394(02)02147-5","article-title":"Improved functional visual acuity after punctal occlusion in dry eye patients","volume":"135","author":"Goto","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib265","first-page":"490","article-title":"Treatment progress of large-size puncta and clinical investigation of the extrusion rate and other complications associated with large-size punctal plugs","volume":"118","author":"Kimura","year":"2014","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.jtos.2017.05.006_bib266","doi-asserted-by":"crossref","first-page":"e76121","DOI":"10.1371\/journal.pone.0076121","article-title":"Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfaction","volume":"8","author":"Schaumberg","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib267","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.exer.2003.09.020","article-title":"Non-invasive methods of assessing the tear film","volume":"78","author":"Yokoi","year":"2004","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib268","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1167\/iovs.09-4349","article-title":"Tear meniscus volume in dry eye after punctal occlusion","volume":"51","author":"Chen","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib269","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jtos.2014.12.001","article-title":"Clinical guidelines for management of dry eye associated with Sj\u00f6gren disease","volume":"13","author":"Foulks","year":"2015","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2017.05.006_bib270","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/OPTH.S28886","article-title":"Clinical evaluation of the therapeutic effects of atelocollagen absorbable punctal plugs","volume":"6","author":"Hirai","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"Pt B","key":"10.1016\/j.jtos.2017.05.006_bib271","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/978-1-4615-0717-8_186","article-title":"Atelocollagen punctal occlusion for the treatment of the dry eye","volume":"506","author":"Hamano","year":"2002","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib272","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.ico.0000164783.10667.a4","article-title":"Atelocollagen punctal occlusion in dry eye patients","volume":"25","author":"Miyata","year":"2006","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib273","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000272022","article-title":"Preparation and clinical evaluation of succinylated collagen punctal plugs in dry eye syndrome: a pilot study","volume":"43","author":"Hadassah","year":"2010","journal-title":"Ophthalmic Res"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib274","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/ICO.0000000000000325","article-title":"Prospective evaluation of hypromellose 2% for punctal occlusion in patients with dry eye","volume":"34","author":"Capita","year":"2015","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib275","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/IOP.0b013e318031d62a","article-title":"Lodged intracanalicular plugs as a cause of lacrimal obstruction","volume":"23","author":"Mazow","year":"2007","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.jtos.2017.05.006_bib276","unstructured":"ClinicalTrialsWebsite. Tolerability, Safety and Efficacy of Lubricin (150 \u03bcg\/ml) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops in Patients With Moderate Dry Eye (DE). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02507934?term=lubricin&rank=22015."},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib277","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00296-010-1527-x","article-title":"Clinical efficacy of the SmartPlug\u2122 in the treatment of primary Sjogren's syndrome with keratoconjunctivitis sicca: one-year follow-up study","volume":"31","author":"Egrilmez","year":"2011","journal-title":"Rheumatol Int"},{"issue":"1859","key":"10.1016\/j.jtos.2017.05.006_bib278","first-page":"e1","article-title":"Management of complications after insertion of the SmartPlug punctal plug: a study of 28 patients","volume":"113","author":"SmartPlug Study","year":"2006","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib279","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/02713683.2013.765487","article-title":"Collared silicone punctal plugs compared to intracanalicular plugs for the treatment of dry eye","volume":"38","author":"Rabensteiner","year":"2013","journal-title":"Curr Eye Res"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib280","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/01676831003664376","article-title":"Complications of intracanalicular plugs: a case series","volume":"29","author":"Joganathan","year":"2010","journal-title":"Orbit"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib281","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0039-6257(96)82013-3","article-title":"Treatment of dry eye by blocking the lacrimal canaliculi","volume":"40","author":"Murube","year":"1996","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib282","first-page":"24","article-title":"Punctal occlusion with n-butyl cyanoacrylate tissue adhesive","volume":"7","author":"Patten","year":"1976","journal-title":"Ophthalmic Surg"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib283","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0002-9394(00)00620-6","article-title":"Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome","volume":"131","author":"Balaram","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib284","first-page":"139","article-title":"Clinical investigation of extrusion of a new punctal plug(Flex Plug)","volume":"108","author":"Nishii","year":"2004","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.jtos.2017.05.006_bib285","first-page":"322","article-title":"Comparison of extrusion rate for two different design of punctal plugs","volume":"107","author":"Nishii","year":"2003","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.jtos.2017.05.006_bib286","first-page":"126","article-title":"Clinical investigation of the extrusion rate and other complications of the SuperEagle plug","volume":"117","author":"Sonomura","year":"2013","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib287","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ajo.2007.05.019","article-title":"Long-term retention rates and complications of silicone punctal plugs in dry eye","volume":"144","author":"Horwath-Winter","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib288","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajo.2012.10.024","article-title":"Comparison of retention rates and complications of 2 different types of silicon lacrimal punctal plugs in the treatment of dry eye disease","volume":"155","author":"Kaido","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib289","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00003226-200404000-00006","article-title":"Efficacy and retention rate of two types of silicone punctal plugs in patients with and without Sj\u00f6gren syndrome","volume":"23","author":"Sakamoto","year":"2004","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib290","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00003226-199705000-00022","article-title":"Silicone punctal plug migration resulting in dacryocystitis and canaliculitis","volume":"16","author":"Rumelt","year":"1997","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib291","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00417-006-0462-8","article-title":"Bilateral canaliculitis following SmartPLUG insertion for dry eye syndrome post LASIK surgery","volume":"245","author":"Scheepers","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib292","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0021-5155(00)00214-8","article-title":"Acute conjunctivitis associated with biofilm formation on a punctal plug","volume":"44","author":"Yokoi","year":"2000","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib293","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/IOP.0b013e3181b57c01","article-title":"Canaliculitis with a papilloma-like mass caused by a temporary punctal plug","volume":"25","author":"Ahn","year":"2009","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib294","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/01676830.2011.648802","article-title":"A review of the complications of lacrimal occlusion with punctal and canalicular plugs","volume":"31","author":"Bourkiza","year":"2012","journal-title":"Orbit"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib295","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0161-6420(78)35555-X","article-title":"Punctal occlusion in keratoconjunctivitis sicca","volume":"85","author":"Dohlman","year":"1978","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2017.05.006_bib296","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000131091","article-title":"Surgical occlusion of the lacrimal drainage system","volume":"41","author":"Geerling","year":"2008","journal-title":"Dev Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib297","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajo.2010.08.045","article-title":"Surgical punctal occlusion with a high heat-energy releasing cautery device for severe dry eye with recurrent punctal plug extrusion","volume":"151","author":"Ohba","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib298","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/02713683.2011.569870","article-title":"Two-year outcome of partial lacrimal punctal occlusion in the management of dry eye related to Sj\u00f6gren syndrome","volume":"36","author":"Holzchuh","year":"2011","journal-title":"Curr Eye Res"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib299","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/IOP.0000000000000313","article-title":"Lacrimal Punctal Occlusion With Conjunctival Flap","volume":"31","author":"Yazici","year":"2015","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib300","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000329837","article-title":"'Punctal switch' grafting for the treatment of dry eyes: our experience","volume":"46","author":"Panagopoulos","year":"2011","journal-title":"Ophthalmic Res"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib301","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajo.2005.09.028","article-title":"A technique for preventing spontaneous loss of lacrimal punctal plugs","volume":"141","author":"Obata","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib302","first-page":"478","article-title":"Canaliculectomy in the treatment of keratitis sicca","volume":"22","author":"Putterman","year":"1991","journal-title":"Ophthalmic Surg"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib303","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/01.iop.0000231773.20993.79","article-title":"A permanent and reversible procedure to block tear drainage for the treatment of dry eye","volume":"22","author":"DeMartelaere","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib304","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ophtha.2003.09.034","article-title":"Punctal occlusion in the management of chronic Stevens-Johnson syndrome","volume":"111","author":"Kaido","year":"2004","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib305","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0002-9394(89)90123-2","article-title":"A comparison of two methods of punctal occlusion","volume":"108","author":"Knapp","year":"1989","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib306","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/ICO.0b013e318074e460","article-title":"Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye","volume":"26","author":"Roberts","year":"2007","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib307","first-page":"CD006775","article-title":"Punctal occlusion for dry eye syndrome","author":"Ervin","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtos.2017.05.006_bib308","first-page":"360","article-title":"Outcome of punctal plug occlusion therapy for severe dry eye syndrome","volume":"106","author":"Kojima","year":"2002","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib309","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00003226-200301000-00003","article-title":"Effects of lacrimal occlusion with collagen and silicone plugs on patients with conjunctivitis associated with dry eye","volume":"22","author":"Nava-Castaneda","year":"2003","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1475-1313.2003.00081.x","article-title":"A clinical procedure to predict the value of temporary occlusion therapy in keratoconjunctivitis sicca","volume":"23","author":"Farrell","year":"2003","journal-title":"Ophthalmic Physiol Opt"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib311","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajo.2005.02.031","article-title":"Silicone versus collagen plugs for treating dry eye: results of a prospective randomized trial including lacrimal scintigraphy","volume":"140","author":"Altan-Yaycioglu","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib312","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/ICO.0b013e318038d2cd","article-title":"SmartPlug in the management of severe dry eye syndrome","volume":"26","author":"Chen","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib313","first-page":"151","article-title":"Effects of silicone punctal plugs for tear deficiency dry eye patients","volume":"49","author":"Shi","year":"2013","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib314","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3928\/0191-3913-19780101-16","article-title":"A new approach to ocular moisture chambers","volume":"15","author":"Savar","year":"1978","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib315","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00006324-198409000-00014","article-title":"Combination of a side shield with an ocular moisture chamber","volume":"61","author":"Gresset","year":"1984","journal-title":"Am J Optom Physiol Opt"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib316","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/OPX.0000000000000778","article-title":"Effect of Moisture Chamber Spectacles on Tear Functions in Dry Eye Disease","volume":"93","author":"Shen","year":"2016","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib317","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.clae.2012.08.088","article-title":"Dry eye relief for VDU users from a USB-desktop humidifier","volume":"35","author":"Craig","year":"2012","journal-title":"Contact Lens Anter Eye"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib318","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3109\/02713683.2014.967871","article-title":"Diquafosol Tetrasodium Increases the Concentration of Mucin-like Substances in Tears of Healthy Human Subjects","volume":"40","author":"Shigeyasu","year":"2015","journal-title":"Curr Eye Res"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib319","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/10807680260218524","article-title":"INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model","volume":"18","author":"Fujihara","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2017.05.006_bib320","first-page":"327","article-title":"P2Y2 receptor agonists for the treatment of dry eye disease: a review","volume":"8","author":"Lau","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib321","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/bjophthalmol-2014-306084","article-title":"A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore","volume":"99","author":"Gong","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib322","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1517\/17425255.2014.915026","article-title":"Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sj\u00f6gren's syndrome","volume":"10","author":"Bremond-Gignac","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib323","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10384-013-0251-y","article-title":"Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye","volume":"57","author":"Koh","year":"2013","journal-title":"Jpn J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib324","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/ICO.0b013e3182930b1d","article-title":"Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye","volume":"32","author":"Shimazaki-Den","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib325","first-page":"2251","article-title":"Real-world assessment of diquafosol in dry eye patients with risk factors such as contact lens, meibomian gland dysfunction, and conjunctivochalasis: subgroup analysis from a prospective observational study","volume":"9","author":"Yamaguchi","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib326","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/ICO.0000000000000136","article-title":"Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis","volume":"33","author":"Mori","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib327","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajo.2015.12.002","article-title":"Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial","volume":"163","author":"Park","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib328","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.exer.2015.10.013","article-title":"Diquafosol promotes corneal epithelial healing via intracellular calcium-mediated ERK activation","volume":"143","author":"Byun","year":"2016","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib329","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jtos.2015.11.003","article-title":"Report of the Inaugural Meeting of the TFOS i(2) = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment","volume":"14","author":"Chao","year":"2016","journal-title":"Ocul Surf"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib330","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1167\/iovs.10-6220","article-title":"Lacritin, a novel human tear glycoprotein, promotes sustained basal tearing and is well tolerated","volume":"52","author":"Samudre","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib331","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1167\/iovs.14-13924","article-title":"Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease","volume":"55","author":"Vijmasi","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib332","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/02713683.2013.834939","article-title":"Regulation of human corneal epithelial mucins by rebamipide","volume":"39","author":"Itoh","year":"2014","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib333","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ajo.2013.11.010","article-title":"A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye","volume":"157","author":"Kinoshita","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib334","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/ICO.0b013e318294f97e","article-title":"Effect of rebamipide ophthalmic suspension on optical quality in the short break-up time type of dry eye","volume":"32","author":"Koh","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib335","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2147\/OPTH.S54511","article-title":"Topical rebamipide improves lid wiper epitheliopathy","volume":"7","author":"Itakura","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib336","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000369201","article-title":"Alkali burn treated with 2% rebamipide ophthalmic suspension: a case report","volume":"5","author":"Sasaki","year":"2014","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib337","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2147\/OPTH.S40798","article-title":"Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal","volume":"8","author":"Kashima","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib338","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/ICO.0000000000000456","article-title":"Effect of Rebamipide Ophthalmic Suspension on Intraocular Light Scattering for Dry Eye After Corneal Refractive Surgery","volume":"34","author":"Igarashi","year":"2015","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib339","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ajo.2015.02.008","article-title":"Alteration of galectin-3 in tears of patients with dry eye disease","volume":"159","author":"Uchino","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib340","doi-asserted-by":"crossref","first-page":"10248","DOI":"10.1038\/srep10248","article-title":"JBP485 promotes tear and mucin secretion in ocular surface epithelia","volume":"5","author":"Nakamura","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2017.05.006_bib341","first-page":"1913","article-title":"Effects of mycophenolate mofetil on proliferation and mucin-5AC expression in human conjunctival goblet cells in vitro","volume":"16","author":"He","year":"2010","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtos.2017.05.006_bib342","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4196\/kjpp.2014.18.2.89","article-title":"DA-6034 Induces [Ca(2+)]i Increase in Epithelial Cells","volume":"18","author":"Yang","year":"2014","journal-title":"Korean J Physiol Pharmacol"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib343","first-page":"498","article-title":"Effects of DA-6034, a flavonoid derivative, on mucin-like glycoprotein and ocular surface integrity in a rabbit model","volume":"59","author":"Choi","year":"2009","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jtos.2017.05.006_bib344","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000315014","article-title":"Trefoil factor family peptide 3 at the ocular surface. A promising therapeutic candidate for patients with dry eye syndrome?","volume":"45","author":"Schulze","year":"2010","journal-title":"Dev Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib345","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1167\/iovs.13-13423","article-title":"Trefoil factor family peptide 3 (TFF3) is upregulated under experimental conditions similar to dry eye disease and supports corneal wound healing effects in vitro","volume":"55","author":"Schulze","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib346","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1167\/iovs.08-2716","article-title":"In vitro evidence of nerve growth factor effects on human conjunctival epithelial cell differentiation and mucin gene expression","volume":"50","author":"Lambiase","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib347","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jamaophthalmol.2013.8295","article-title":"The effects of insulin-like growth factor 1 and growth hormone on human meibomian gland epithelial cells","volume":"132","author":"Ding","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib348","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1167\/iovs.05-0426","article-title":"Androgen control of gene expression in the mouse meibomian gland","volume":"46","author":"Schirra","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib349","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.exer.2005.11.026","article-title":"Androgen regulation of lipogenic pathways in the mouse meibomian gland","volume":"83","author":"Schirra","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib350","first-page":"1553","article-title":"Do sex steroids exert sex-specific and\/or opposite effects on gene expression in lacrimal and meibomian glands?","volume":"15","author":"Sullivan","year":"2009","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtos.2017.05.006_bib351","first-page":"1055","article-title":"Androgen regulation of gene expression in human meibomian gland and conjunctival epithelial cells","volume":"18","author":"Khandelwal","year":"2012","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtos.2017.05.006_bib352","article-title":"A multi-center, double-masked, randomized, vehicle-controlled, parallel group study to evaluate the safety and efficacy of testosterone ophthalmic solution in patients with meibomian gland dysfunction","volume":"47","author":"Schiffman","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib353","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jtos.2017.04.001","article-title":"TFOS DEWS II Sex, Gender, and Hormones report","volume":"15","author":"Sullivan","year":"2017","journal-title":"Ocul Surf"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib354","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/ard.2002.003889","article-title":"Oral pilocarpine for the treatment of ocular symptoms in patients with Sj\u00f6gren's syndrome: a randomised 12 week controlled study","volume":"62","author":"Tsifetaki","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib355","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/APO.0000000000000040","article-title":"Effect of Oral Pilocarpine in Treating Severe Dry Eye in Patients With Sj\u00f6gren Syndrome","volume":"4","author":"Kawakita","year":"2015","journal-title":"Asia Pac J Ophthalmol Phila"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib356","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/bjo.2005.078865","article-title":"Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome","volume":"90","author":"Aragona","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib357","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/ICO.0b013e318261eb4a","article-title":"Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with sj\u00f6gren syndrome","volume":"32","author":"Ibrahim","year":"2013","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib358","first-page":"575","article-title":"Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sj\u00f6gren's syndrome","volume":"32","author":"Noaiseh","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib359","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/art.510","article-title":"A double-blind, randomized, placebo-controlled study of cevimeline in Sj\u00f6gren's syndrome patients with xerostomia and keratoconjunctivitis sicca","volume":"46","author":"Petrone","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib360","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajo.2004.02.010","article-title":"Therapeutic effect of cevimeline on dry eye in patients with Sj\u00f6gren's syndrome: a randomized, double-blind clinical study","volume":"138","author":"Ono","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib361","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jama.2010.1014","article-title":"Treatment of primary Sjogren syndrome: a systematic review","volume":"304","author":"Ramos-Casals","year":"2010","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib362","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ophtha.2010.12.016","article-title":"Treatment of Sj\u00f6gren's syndrome-associated dry eye an evidence-based review","volume":"118","author":"Akpek","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib363","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/IOP.0000000000000234","article-title":"Neurostimulation of the lacrimal nerve for enhanced tear production","volume":"31","author":"Kossler","year":"2015","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"7444","key":"10.1016\/j.jtos.2017.05.006_bib364","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/496159a","article-title":"Drug discovery: a jump-start for electroceuticals","volume":"496","author":"Famm","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib365","first-page":"218","article-title":"On the sneeze-reflex and its control","volume":"45","author":"Hyd\u00e9n","year":"2007","journal-title":"Rhinology"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib366","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/IIO.0000000000000163","article-title":"Intranasal Tear Neurostimulation: An Emerging Concept in the Treatment of Dry Eye","volume":"57","author":"Gumus","year":"2017","journal-title":"Int Ophthalmol Clin"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib367","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1513\/pats.201007-049RN","article-title":"How nasal function influences the eyes, ears, sinuses, and lungs","volume":"8","author":"Baroody","year":"2011","journal-title":"Proc Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib368","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003226-199711000-00008","article-title":"Nasolacrimal stimulation of aqueous tear production","volume":"16","author":"Gupta","year":"1997","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib369","first-page":"795","article-title":"A nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease","volume":"10","author":"Friedman","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib370","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ajo.2017.03.002","article-title":"Randomized Controlled Crossover Trial Comparing the Impact of Sham or Intranasal Tear Neurostimulation on Conjunctival Goblet Cell Degranulation","volume":"177","author":"Gumus","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib371","first-page":"160041","article-title":"Evaluating the Safety and Efficacy of Intranasal Neurostimulation for Dry Eye Disease: A Double-masked, Randomized, Controlled, Multicenter Study","volume":"94","author":"Craig","year":"2016","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib372","first-page":"160057","article-title":"Symptom Reduction with Oculeve Intranasal Stimulator on Exposure to Environmental Challenge in Dry Eye: A Randomized, Controlled, Crossover Trial","volume":"94","author":"Craig","year":"2016","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib373","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jtos.2014.08.002","article-title":"Abdominal breathing increases tear secretion in healthy women","volume":"13","author":"Sano","year":"2015","journal-title":"Ocul Surf"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib374","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1167\/iovs.09-4744","article-title":"Cold-sensitive corneal afferents respond to a variety of ocular stimuli central to tear production: implications for dry eye disease","volume":"51","author":"Hirata","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib375","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1167\/iovs.09-5119","article-title":"Cold thermoreceptors, unexpected players in tear production and ocular dryness sensations","volume":"52","author":"Belmonte","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7150","key":"10.1016\/j.jtos.2017.05.006_bib376","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/448147a","article-title":"Neurophysiology: channelling cold reception","volume":"448","author":"Nilius","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib377","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/j.pain.0000000000000455","article-title":"Abnormal activity of corneal cold thermoreceptors underlies the unpleasant sensations in dry eye disease","volume":"157","author":"Kov\u00e1cs","year":"2016","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib378","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/OPX.0000000000000129","article-title":"The effect of caffeine on tear secretion","volume":"91","author":"Osei","year":"2014","journal-title":"Optom Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib379","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/eye.1991.65","article-title":"Meibomian gland disease. Classification and grading of lid changes","volume":"5","author":"Bron","year":"1991","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib380","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1167\/iovs.10-6997d","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease","volume":"52","author":"Green-Church","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib381","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0161-6420(82)34669-2","article-title":"Classification of chronic blepharitis","volume":"89","author":"McCulley","year":"1982","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib382","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00003226-200009000-00010","article-title":"Changing concepts in the diagnosis and management of blepharitis","volume":"19","author":"McCulley","year":"2000","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib383","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1167\/iovs.10-6997","article-title":"The international workshop on meibomian gland dysfunction: introduction","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib384","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib385","first-page":"200","article-title":"Chronic blepharitis: a review","volume":"21","author":"Smith","year":"1995","journal-title":"CLAO J"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib386","first-page":"209","article-title":"A comparative study of eyelid cleaning regimens in chronic blepharitis","volume":"22","author":"Key","year":"1996","journal-title":"CLAO J"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib387","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.ICL.0000095229.01957.89","article-title":"Conservative treatment of meibomian gland dysfunction","volume":"30","author":"Romero","year":"2004","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2017.05.006_bib388","article-title":"Commercial lid cleanser outperforms baby shampoo for management of blepharitis in randomized, double-masked clinical trial","volume":"58","author":"Craig","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib389","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib390","doi-asserted-by":"crossref","DOI":"10.1097\/ICL.0000000000000258","article-title":"Compliance and Subjective Patient Responses to Eyelid Hygiene","author":"Alghamdi","year":"2017","journal-title":"Eye Contact Lens"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib391","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1542-0124(12)70031-9","article-title":"Ocular effects of cosmetic products and procedures","volume":"4","author":"Coroneo","year":"2006","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib392","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/ICO.0b013e3181bd4756","article-title":"Cosmetic product migration onto the ocular surface: exacerbation of migration after eyedrop instillation","volume":"29","author":"Goto","year":"2010","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib393","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/ICL.0000000000000124","article-title":"Migration of Cosmetic Products into the Tear Film","volume":"41","author":"Ng","year":"2015","journal-title":"Eye Contact Lens"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib394","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00006324-199011000-00002","article-title":"Meibomian therapy in problematic contact lens wear","volume":"67","author":"Paugh","year":"1990","journal-title":"Optom Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib395","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/ICL.0b013e318268305a","article-title":"Eyelid margin modification associated with eyelid hygiene in anterior blepharitis and meibomian gland dysfunction","volume":"38","author":"Guillon","year":"2012","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib396","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/ICL.0b013e3182658699","article-title":"Symptomatic relief associated with eyelid hygiene in anterior blepharitis and MGD","volume":"38","author":"Guillon","year":"2012","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2017.05.006_bib397","first-page":"71","article-title":"Tolerability and acceptability of Blephagel: a novel eyelid hygiene aqueous gel","volume":"6","author":"Doan","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib398","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00347-012-2725-6","article-title":"Eyelid hygiene for contact lens wearers with blepharitis. Comparative investigation of treatment with baby shampoo versus phospholipid solution","volume":"110","author":"Khaireddin","year":"2013","journal-title":"Ophthalmologe"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib399","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.oftal.2013.09.003","article-title":"Comparative study of the efficacy of different treatment options in patients with chronic blepharitis","volume":"90","author":"Arr\u00faa","year":"2015","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib400","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.optom.2016.05.001","article-title":"The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals","volume":"10","author":"Ngo","year":"2017","journal-title":"J Optom"},{"key":"10.1016\/j.jtos.2017.05.006_bib401","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2147\/OPTH.S33133","article-title":"How to promote and preserve eyelid health","volume":"6","author":"Benitez-Del-Castillo","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib402","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1475-1313.2008.00551.x","article-title":"A survey of the scope of therapeutic practice by UK optometrists and their attitudes to an extended prescribing role","volume":"28","author":"Needle","year":"2008","journal-title":"Ophthalmic Physiol Opt"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib403","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3129\/i09-015","article-title":"Management of dysfunctional tear syndrome: a Canadian consensus","volume":"44","author":"Jackson","year":"2009","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib404","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/09286586.2011.642052","article-title":"Association of blepharitis with Demodex: a meta-analysis","volume":"19","author":"Zhao","year":"2012","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.jtos.2017.05.006_bib405","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2008-1034943","article-title":"Topical administration of metronidazole gel as an effective therapy alternative in chronic Demodex blepharitis\u2013a case report","volume":"213","author":"Junk","year":"1998","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.jtos.2017.05.006_bib406","first-page":"63","article-title":"Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis","volume":"53","author":"Czepita","year":"2007","journal-title":"Ann Acad Med Stetin"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib407","first-page":"637","article-title":"A case report of demodicosis","volume":"61","author":"Fulk","year":"1990","journal-title":"J Am Optom Assoc"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib408","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00006324-199612000-00004","article-title":"Pilocarpine gel for the treatment of demodicosis-a case series","volume":"73","author":"Fulk","year":"1996","journal-title":"Optom Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib409","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ajo.2007.01.054","article-title":"Corneal manifestations of ocular demodex infestation","volume":"143","author":"Kheirkhah","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib410","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.ico.0000244870.62384.79","article-title":"Clinical treatment of ocular demodecosis by lid scrub with tea tree oil","volume":"26","author":"Gao","year":"2007","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib411","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ajo.2010.11.024","article-title":"Clinical treatment of ocular Demodex folliculorum by systemic ivermectin","volume":"151","author":"Holzchuh","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib412","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bjo.2010.201194","article-title":"The efficacy of oral ivermectin for the treatment of chronic blepharitis in patients tested positive for Demodex spp","volume":"95","author":"Filho","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib413","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3346\/jkms.2012.27.12.1574","article-title":"Ocular surface discomfort and Demodex: effect of tea tree oil eyelid scrub in Demodex blepharitis","volume":"27","author":"Koo","year":"2012","journal-title":"J Korean Med Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib414","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/ICO.0b013e31820ce56c","article-title":"Treatment of ocular itching associated with ocular demodicosis by 5% tea tree oil ointment","volume":"31","author":"Gao","year":"2012","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib415","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1016\/j.ijid.2012.11.022","article-title":"Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum","volume":"17","author":"Salem","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib416","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/CMR.19.1.50-62.2006","article-title":"Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties","volume":"19","author":"Carson","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib417","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/bjo.2005.072363","article-title":"In vitro and in vivo killing of ocular Demodex by tea tree oil","volume":"89","author":"Gao","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib418","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.2.7.2","article-title":"Terpinen-4-ol is the Most Active Ingredient of Tea Tree Oil to Kill Demodex Mites","volume":"2","author":"Tighe","year":"2013","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib419","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/ICU.0000000000000168","article-title":"Recent advances on ocular Demodex infestation","volume":"26","author":"Cheng","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib420","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10792-016-0188-5","article-title":"Demodex treatment in external ocular disease: the outcomes of a Tasmanian case series","volume":"36","author":"Nicholls","year":"2016","journal-title":"Int Ophthalmol"},{"issue":"5 Pt 1","key":"10.1016\/j.jtos.2017.05.006_bib421","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0190-9622(99)70022-8","article-title":"Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream","volume":"41","author":"Forstinger","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib422","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ICO.0b013e31821b71e6","article-title":"Effectiveness of artificial tears in the management of evaporative dry eye","volume":"31","author":"McCann","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib423","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2147\/OPTH.S35833","article-title":"Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction","volume":"7","author":"Sindt","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib424","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2147\/OPTH.S70623","article-title":"Effects of Systane(\u00ae) Balance on noninvasive tear film break-up time in patients with lipid-deficient dry eye","volume":"8","author":"Aguilar","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib425","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2147\/OPTH.S58464","article-title":"A prospective, multicenter, noninterventional study of Optive Plus(\u00ae) in the treatment of patients with dry eye: the prolipid study","volume":"8","author":"Kaercher","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib426","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/ICL.0000000000000138","article-title":"A Comparative Study Between an Oil-in-Water Emulsion and Nonlipid Eye Drops Used for Rewetting Contact Lenses","volume":"41","author":"Guthrie","year":"2015","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2017.05.006_bib427","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/OPTH.S75297","article-title":"An evaluation of Retaine\u2122 ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye","volume":"9","author":"Ousler","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"5\u20136","key":"10.1016\/j.jtos.2017.05.006_bib428","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drudis.2012.10.005","article-title":"Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers","volume":"18","author":"Gan","year":"2013","journal-title":"Drug Discov Today"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2017.05.006_bib429","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40123-014-0025-8","article-title":"A Randomized, Controlled Treatment Trial of Eyelid-Warming Therapies in Meibomian Gland Dysfunction","volume":"3","author":"Sim","year":"2014","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib430","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10792-014-9947-3","article-title":"Evaluation of a novel eyelid-warming device in meibomian gland dysfunction unresponsive to traditional warm compress treatment: an in vivo confocal study","volume":"35","author":"Villani","year":"2015","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib431","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clae.2015.01.005","article-title":"Ex vivo heat retention of different eyelid warming masks","volume":"38","author":"Lacroix","year":"2015","journal-title":"Cont Lens Anter Eye"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib432","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clae.2016.04.002","article-title":"In-vivo heat retention comparison of eyelid warming masks","volume":"39","author":"Bitton","year":"2016","journal-title":"Cont Lens Anter Eye"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib433","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1097\/OPX.0000000000000675","article-title":"All Warm Compresses Are Not Equally Efficacious","volume":"92","author":"Murakami","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib434","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1542-0124(12)70150-7","article-title":"The contribution of meibomian disease to dry eye","volume":"2","author":"Bron","year":"2004","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib435","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1167\/iovs.06-0753","article-title":"Identification of fatty acids and fatty acid amides in human meibomian gland secretions","volume":"48","author":"Nichols","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib436","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.ICL.0000060998.20142.8D","article-title":"Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction","volume":"29","author":"Olson","year":"2003","journal-title":"Eye Contact Lens"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib437","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/ICO.0b013e3181d4f366","article-title":"Nonobvious obstructive meibomian gland dysfunction","volume":"29","author":"Blackie","year":"2010","journal-title":"Cornea"},{"issue":"Pt B","key":"10.1016\/j.jtos.2017.05.006_bib438","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/978-1-4615-0717-8_161","article-title":"Improvement of tear stability following warm compression in patients with meibomian gland dysfunction","volume":"506","author":"Goto","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtos.2017.05.006_bib439","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-024922-0.50005-9","article-title":"The lipid secretion of the meibomian glands","volume":"22","author":"Tiffany","year":"1987","journal-title":"Adv Lipid Res"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib440","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1475-1313.1990.tb00968.x","article-title":"Meibomian gland dysfunction: some clinical, biochemical and physical observations","volume":"10","author":"Ong","year":"1990","journal-title":"Ophthalmic Physiol Opt"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib441","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/ICO.0b013e3181814cff","article-title":"Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location","volume":"27","author":"Korb","year":"2008","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib442","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jtos.2015.04.005","article-title":"Effects of Eyelid Warming Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland Dysfunction","volume":"13","author":"Arita","year":"2015","journal-title":"Ocul Surf"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib443","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/OPX.0b013e318181adef","article-title":"Inner eyelid surface temperature as a function of warm compress methodology","volume":"85","author":"Blackie","year":"2008","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib444","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1038\/srep09541","article-title":"The Core Pattern Analysis on Chinese Herbal Medicine for Sj\u00f6gren's syndrome: A Nationwide Population-Based Study","volume":"5","author":"Chang","year":"2015","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib445","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.burns.2005.01.015","article-title":"The relative thermal stability of tissue macromolecules and cellular structure in burn injury","volume":"31","author":"Despa","year":"2005","journal-title":"Burns"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib446","first-page":"695","article-title":"Studies of Thermal Injury: II. The Relative Importance of Time and Surface Temperature in the Causation of Cutaneous Burns","volume":"23","author":"Moritz","year":"1947","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2017.05.006_bib447","doi-asserted-by":"crossref","first-page":"e10269","DOI":"10.1371\/journal.pone.0010269","article-title":"The fine tuning of pain thresholds: a sophisticated double alarm system","volume":"5","author":"Plaghki","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib448","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1097\/ICO.0b013e318292a7b7","article-title":"Warm compresses and the risks of elevated corneal temperature with massage","volume":"32","author":"Blackie","year":"2013","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib449","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/OPX.0b013e3180dc99d5","article-title":"Warm compress induced visual degradation and Fischer-Schweitzer polygonal reflex","volume":"84","author":"Solomon","year":"2007","journal-title":"Optom Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib450","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.clae.2012.01.001","article-title":"The role of heat in rubbing and massage-related corneal deformation","volume":"35","author":"McMonnies","year":"2012","journal-title":"Cont Lens Anter Eye"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib451","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1194\/jlr.P051185","volume":"55","author":"Man Lam","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib452","first-page":"5601","article-title":"Effects of novel eye warming goggles on the tear film","volume":"47","author":"Pearce","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib453","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1097\/OPX.0b013e31825c3479","article-title":"A comparison of an eyelid-warming device to traditional compress therapy","volume":"89","author":"Pult","year":"2012","journal-title":"Optom Vis Sci"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib454","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jfo.2014.06.004","article-title":"Evaluation of an eyelid warming device (Blephasteam) for the management of ocular surface diseases in France: the ESPOIR study","volume":"37","author":"Doan","year":"2014","journal-title":"J Fr Ophtalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib455","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clae.2015.06.002","article-title":"Temperature profiles of patient-applied eyelid warming therapies","volume":"38","author":"Wang","year":"2015","journal-title":"Cont Lens Anter Eye"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib456","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1136\/bjophthalmol-2014-305220","article-title":"Randomised masked clinical trial of the MGDRx EyeBag for the treatment of meibomian gland dysfunction-related evaporative dry eye","volume":"98","author":"Bilkhu","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib457","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1097\/OPX.0000000000000601","article-title":"Comparison of Self-applied Heat Therapy for Meibomian Gland Dysfunction","volume":"92","author":"Wang","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib458","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1136\/bjo.86.12.1403","article-title":"Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device","volume":"86","author":"Goto","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib459","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/ICO.0b013e318239aaea","article-title":"A new system, the LipiFlow, for the treatment of meibomian gland dysfunction","volume":"31","author":"Lane","year":"2012","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib460","first-page":"223","article-title":"Displacement technique and meibomian gland expression","volume":"58","author":"Hom","year":"1987","journal-title":"J Am Optom Assoc"},{"key":"10.1016\/j.jtos.2017.05.006_bib461","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-1-4615-2417-5_50","article-title":"Increase in tear film lipid layer thickness following treatment of meibomian gland dysfunction","volume":"350","author":"Korb","year":"1994","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib462","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0002-9394(77)90497-4","article-title":"Meibomian keratoconjunctivitis","volume":"84","author":"McCulley","year":"1977","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib463","first-page":"243","article-title":"Meibomian gland dysfunction and contact lens intolerance","volume":"51","author":"Korb","year":"1980","journal-title":"J Am Optom Assoc"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib464","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/ICL.0b013e31821bc7c5","article-title":"Meibomian gland therapeutic expression: quantifying the applied pressure and the limitation of resulting pain","volume":"37","author":"Korb","year":"2011","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib465","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/ICU.0000000000000165","article-title":"Treatment for meibomian gland dysfunction and dry eye symptoms with a single-dose vectored thermal pulsation: a review","volume":"26","author":"Blackie","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib466","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/ICO.0000000000000273","article-title":"Six-month effects of a thermodynamic treatment for MGD and implications of meibomian gland atrophy","volume":"33","author":"Finis","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib467","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2147\/OPTH.S109663","article-title":"The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye","volume":"10","author":"Blackie","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib468","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ICL.0000000000000166","article-title":"Long-Term (3 Year) Effects of a Single Thermal Pulsation System Treatment on Meibomian Gland Function and Dry Eye Symptoms","volume":"42","author":"Greiner","year":"2016","journal-title":"Eye Contact Lens"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib469","first-page":"45","article-title":"Current trends in intense pulsed light","volume":"5","author":"Goldberg","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib470","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1167\/iovs.14-15764","article-title":"Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction","volume":"56","author":"Craig","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib471","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/ICO.0000000000000735","article-title":"Combination Therapy of Intense Pulsed Light Therapy and Meibomian Gland Expression (IPL\/MGX) Can Improve Dry Eye Symptoms and Meibomian Gland Function in Patients With Refractory Dry Eye: A Retrospective Analysis","volume":"35","author":"Vegunta","year":"2016","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib472","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcjo.2016.01.005","article-title":"Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease","volume":"51","author":"Gupta","year":"2016","journal-title":"Can J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib473","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/ICO.0b013e3181d836f3","article-title":"Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction","volume":"29","author":"Maskin","year":"2010","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib474","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.oftal.2014.04.014","article-title":"Intraductal meibomian gland probing for the treatment of blepharitis","volume":"90","author":"Fermon","year":"2015","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib475","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/ICO.0000000000000558","article-title":"Analysis of Meibum Before and After Intraductal Meibomian Gland Probing in Eyes With Obstructive Meibomian Gland Dysfunction","volume":"34","author":"Nakayama","year":"2015","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib476","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/IOP.0b013e3182627ebc","article-title":"Intraductal meibomian gland probing in the management of ocular rosacea","volume":"28","author":"Wladis","year":"2012","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib477","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland","volume":"52","author":"Knop","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib478","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1097\/ICO.0b013e3182a73843","article-title":"Debridement-scaling: a new procedure that increases Meibomian gland function and reduces dry eye symptoms","volume":"32","author":"Korb","year":"2013","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib479","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1097\/OPX.0000000000000668","article-title":"Effect of Lid Debridement-Scaling in Sj\u00f6gren Syndrome Dry Eye","volume":"92","author":"Ngo","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib480","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clae.2006.12.002","article-title":"Incomplete blinking: exposure keratopathy, lid wiper epitheliopathy, dry eye, refractive surgery, and dry contact lenses","volume":"30","author":"McMonnies","year":"2007","journal-title":"Cont Lens Anter Eye"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib481","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/08820538.2010.488578","volume":"25","author":"Pereira","year":"2010","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib482","first-page":"581","article-title":"Diagnosis of dry eye disease and emerging technologies","volume":"8","author":"Zeev","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib483","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II Pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib484","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archopht.1977.04450030091011","article-title":"Corneal exposure during sleep (nocturnal lagophthalmos)","volume":"95","author":"Katz","year":"1977","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib485","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-0035-1549292","article-title":"Management of the eye in facial paralysis","volume":"31","author":"Sohrab","year":"2015","journal-title":"Facial Plast Surg"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib486","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000365519","article-title":"Lagophthalmos after facial palsy: current therapeutic options","volume":"52","author":"V\u00e1squez","year":"2014","journal-title":"Ophthalmic Res"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib487","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1542-0124(12)70263-X","article-title":"Nocturnal lagophthalmos: an overview and classification","volume":"4","author":"Latkany","year":"2006","journal-title":"Ocul Surf"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib488","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.ijnurstu.2008.02.005","article-title":"Comparing the effectiveness of polyethylene covers (Gladwrap) with lanolin (Duratears) eye ointment to prevent corneal abrasions in critically ill patients: a randomized controlled study","volume":"45","author":"So","year":"2008","journal-title":"Int J Nurs Stud"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib489","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1007\/s00134-004-2203-y","article-title":"A randomised controlled study of the efficacy of hypromellose and Lacri-Lube combination versus polyethylene\/Cling wrap to prevent corneal epithelial breakdown in the semiconscious intensive care patient","volume":"30","author":"Koroloff","year":"2004","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib490","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1177\/019459989010300622","article-title":"Early gold weight eyelid implantation for facial paralysis","volume":"103","author":"Kartush","year":"1990","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jtos.2017.05.006_bib491","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-2008-1035055","article-title":"Rehabilitation of the eye in patients with facial paralyses: indications and results of gold weight implantation","volume":"210","author":"Linder","year":"1997","journal-title":"Klin Monbl Augenheilkd"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib492","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1590\/S0004-27492012000600010","article-title":"Upper eyelid entropion and dry eye in cicatricial trachoma without trichiasis","volume":"75","author":"Lucena","year":"2012","journal-title":"Arq Bras Oftalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib493","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/08820530590931377","article-title":"Adnexal surgery for severe ocular surface disease","volume":"20","author":"Geerling","year":"2005","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib494","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000131075","article-title":"Correction of entropion and ectropion","volume":"41","author":"Hintschich","year":"2008","journal-title":"Dev Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib495","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1442-9071.2011.02503.x","article-title":"Management of upper eyelid cicatricial entropion","volume":"39","author":"Ross","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib496","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.sjopt.2015.12.004","article-title":"Ocular manifestation of Ichthyosis","volume":"30","author":"Al-Amry","year":"2016","journal-title":"Saudi J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib497","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5935\/0004-2749.20150087","article-title":"Eyelid aging: pathophysiology and clinical management","volume":"78","author":"Damasceno","year":"2015","journal-title":"Arq Bras Oftalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib498","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/sj.eye.6702768","article-title":"Clinical evaluation of changes in cornea and tear film after surgery for trachomatous upper lid entropion","volume":"22","author":"Monga","year":"2008","journal-title":"Eye (Lond)"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib499","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00003226-200111000-00002","article-title":"Tarsorrhaphy: clinical experience from a cornea practice","volume":"20","author":"Cosar","year":"2001","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib500","doi-asserted-by":"crossref","first-page":"TFOS183","DOI":"10.1167\/iovs.13-13166","article-title":"The TFOS International Workshop on Contact Lens Discomfort: report of the management and therapy subcommittee","volume":"54","author":"Papas","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib501","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/ICL.0b013e31823ff1f4","article-title":"Development of Methicillin-Resistant Staphylococcus aureus Keratitis in a Dry Eye Patient With a Therapeutic Contact Lens","volume":"38","author":"Koh","year":"2012","journal-title":"Eye Contact Lens Sci Clin Pract"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib502","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ophtha.2012.06.030","article-title":"Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes","volume":"119","author":"Henry","year":"2012","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib503","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.ophtha.2008.04.002","article-title":"The incidence of contact lens-related microbial keratitis in Australia","volume":"115","author":"Stapleton","year":"2008","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib504","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.ophtha.2008.05.003","volume":"115","author":"Dart","year":"2008","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib505","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1056\/NEJM198909213211201","article-title":"The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. Microbial Keratitis Study Group","volume":"321","author":"Schein","year":"1989","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib506","first-page":"204","article-title":"Risk factors with contact lens related suppurative keratitis","volume":"19","author":"Stapleton","year":"1993","journal-title":"CLAO J"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib507","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0896-1549(03)00045-2","article-title":"Therapeutic contact lenses: the role of high-Dk lenses","volume":"16","author":"Foulks","year":"2003","journal-title":"Ophthalmol Clin North Am"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib508","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/ICO.0b013e31829dec39","article-title":"Randomized Controlled Study of Ocular Lubrication Versus Bandage Contact Lens in the Primary Treatment of Recurrent Corneal Erosion Syndrome","volume":"32","author":"Ahad","year":"2013","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib509","first-page":"114","article-title":"Evaluation and management of corneal abrasions","volume":"87","author":"Wipperman","year":"2013","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib510","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/ICU.0000000000000062","article-title":"Alternatives to corneal transplantation for the management of bullous keratopathy","volume":"25","author":"Siu","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib511","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.jcrs.2009.07.015","article-title":"Efficacy of 2 types of silicone hydrogel bandage contact lenses after photorefractive keratectomy","volume":"35","author":"Grentzelos","year":"2009","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib512","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ICL.0000000000000027","article-title":"Monitor corneal epithelial healing under bandage contact lens using ultrahigh-resolution optical coherence tomography after pterygium surgery","volume":"40","author":"Chen","year":"2014","journal-title":"Eye Contact Lens"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib513","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clae.2013.09.012","article-title":"The effects of soft contact lens use on cornea and patient's recovery after autograft pterygium surgery","volume":"37","author":"Daglioglu","year":"2014","journal-title":"Cont Lens Anter Eye"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib514","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.clae.2015.01.014","article-title":"Comparison of Lotrafilcon B and Balafilcon A silicone hydrogel bandage contact lenses in reducing pain and discomfort after photorefractive keratectomy: A contralateral eye study","volume":"38","author":"Mohammadpour","year":"2015","journal-title":"Cont Lens Anter Eye"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib515","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.icl.0000244154.76214.2d","article-title":"Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease","volume":"33","author":"Russo","year":"2007","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2017.05.006_bib516","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/08820538.2015.1114853","article-title":"Understanding Neuropathic Corneal Pain\u2013Gaps and Current Therapeutic Approaches","volume":"31","author":"Goyal","year":"2016","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib517","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/eye.2014.263","article-title":"Neuropathic ocular pain: an important yet underevaluated feature of dry eye","volume":"29","author":"Galor","year":"2015","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib518","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0161-6420(90)32589-7","article-title":"Therapeutic contact lenses","volume":"97","author":"Smiddy","year":"1990","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib519","first-page":"179","article-title":"Therapeutic use of Bausch & Lomb PureVision contact lenses","volume":"27","author":"Lim","year":"2001","journal-title":"CLAO J"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib520","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/ICO.0b013e318155743d","article-title":"Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease","volume":"26","author":"Jacobs","year":"2007","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib521","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/ICL.0b013e318188e205","article-title":"Jupiter scleral lenses in the management of chronic graft versus host disease","volume":"34","author":"Schornack","year":"2008","journal-title":"Eye Contact Lens"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib522","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.bbmt.2007.05.006","article-title":"Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease","volume":"13","author":"Takahide","year":"2007","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib523","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ajo.2009.07.006","article-title":"Vision-Related Function After Scleral Lens Fitting in Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis","volume":"148","author":"Tougeron-Brousseau","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib524","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0002-9394(14)74558-1","article-title":"A gas-permeable scleral contact lens for visual rehabilitation","volume":"109","author":"Schein","year":"1990","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib525","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00003226-199211000-00006","article-title":"Treatment of ocular surface disorders and dry eyes with high gas-permeable scleral lenses","volume":"11","author":"Kok","year":"1992","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib526","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00003226-199503000-00001","article-title":"Medical applications of scleral contact lenses: 1. A retrospective analysis of 343 cases","volume":"14","author":"Tan","year":"1995","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib527","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/ICO.0b013e31825fed01","article-title":"Scleral contact lenses as an alternative to tarsorrhaphy for the long-term management of combined exposure and neurotrophic keratopathy","volume":"32","author":"Weyns","year":"2013","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib528","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/ICU.0b013e328302cc4f","article-title":"Update on scleral lenses","volume":"19","author":"Jacobs","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib529","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/ICL.0000000000000083","article-title":"Scleral lenses: a literature review","volume":"41","author":"Schornack","year":"2015","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib530","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clae.2014.02.002","article-title":"Modern scleral contact lenses: A review","volume":"37","author":"van der Worp","year":"2014","journal-title":"Cont Lens Anter Eye"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib531","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajo.2014.03.012","article-title":"Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lens Therapy for Patients With Ocular Symptoms of Chronic Stevens-Johnson Syndrome","volume":"158","author":"Heur","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib532","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ophtha.2014.08.015","article-title":"Prosthetic Replacement of the Ocular Surface Ecosystem as Treatment for Ocular Surface Disease in Patients with a History of Stevens\u2013Johnson Syndrome\/Toxic Epidermal Necrolysis","volume":"122","author":"Papakostas","year":"2015","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib533","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/ICU.0000000000000171","article-title":"Scleral lens use in dry eye syndrome","volume":"26","author":"Bavinger","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib534","doi-asserted-by":"crossref","DOI":"10.1097\/OPX.0000000000000013","article-title":"Central vault in dry eye patients successfully wearing scleral lens","volume":"90","author":"Sonsino","year":"2013","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib535","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clae.2012.10.082","article-title":"Polymicrobial and microsporidial keratitis in a patient using Boston scleral contact lens for Sjogren's syndrome and ocular cicatricial pemphigoid","volume":"36","author":"Fernandes","year":"2013","journal-title":"Contact Lens Anter Eye"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib536","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.clae.2012.07.006","article-title":"Use of mini scleral contact lenses in moderate to severe dry eye","volume":"35","author":"Alipour","year":"2012","journal-title":"Cont Lens Anter Eye"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib537","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clae.2012.07.009","article-title":"Scleral contact lens management of bilateral exposure and neurotrophic keratopathy","volume":"35","author":"Grey","year":"2012","journal-title":"Cont Lens Anter Eye"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib538","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/ICO.0000000000000381","article-title":"Corneal nerve structure and function after long-term wear of fluid-filled scleral lens","volume":"34","author":"Wang","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib539","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II Pain and Sensation report","volume":"15","author":"Belmonte","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2017.05.006_bib540","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.steroids.2016.04.005","article-title":"Neuroactive steroids, nociception and neuropathic pain: A flashback to go forward","volume":"110","author":"Coronel","year":"2016","journal-title":"Steroids"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib541","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1167\/iovs.05-1281","article-title":"Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline","volume":"47","author":"De Paiva","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib542","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":"Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye","volume":"83","author":"De Paiva","year":"2006","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib543","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.ico.0000240079.24583.a1","article-title":"Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model","volume":"26","author":"Lekhanont","year":"2007","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib544","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ajo.2012.01.034","article-title":"Efficacy of topical blockade of interleukin-1 in experimental dry eye disease","volume":"154","author":"Okanobo","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib545","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1167\/iovs.10-5598","article-title":"In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease","volume":"52","author":"Shafiee","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib546","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1167\/iovs.14-14744","article-title":"Dry eye-induced CCR7+CD11b+ cell lymph node homing is induced by COX-2 activities","volume":"55","author":"Ji","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib547","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0161-6420(99)90171-9","article-title":"Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj\u00f6gren syndrome","volume":"106","author":"Marsh","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2017.05.006_bib548","first-page":"751","article-title":"Nonpreserved topical steroids and lacrimal punctal occlusion for severe keratoconjunctivitis sicca","volume":"75","author":"Sainz De La Maza Serra","year":"2000","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib549","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9394(03)00326-X","article-title":"The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study","volume":"136","author":"Avunduk","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib550","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","article-title":"A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance","volume":"138","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib551","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ophtha.2005.09.033","article-title":"Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients","volume":"113","author":"Lee","year":"2006","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib552","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1631\/jzus.2006.B0675","article-title":"A clinical study of the efficacy of topical corticosteroids on dry eye","volume":"7","author":"Yang","year":"2006","journal-title":"J Zhejiang Univ Sci B"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib553","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/ICO.0b013e3181b765a6","article-title":"Preservative-free low-dose dexamethasone for the treatment of chronic ocular surface disease refractory to standard therapy","volume":"29","author":"Jonisch","year":"2010","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib554","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/ICL.0000000000000049","article-title":"Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%","volume":"40","author":"Sheppard","year":"2014","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib555","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ophtha.2014.11.006","article-title":"Effects of corneal nerve density on the response to treatment in dry eye disease","volume":"122","author":"Kheirkhah","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2017.05.006_bib556","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1097\/MD.0000000000000551","article-title":"Topical fluorometholone treatment for ocular dryness in patients with Sjogren syndrome: a randomized clinical trial in China","volume":"94","author":"Lin","year":"2015","journal-title":"Med Baltim"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib557","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ophtha.2015.09.029","article-title":"Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress","volume":"123","author":"Pinto-Fraga","year":"2016","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib558","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1097\/OPX.0000000000000600","article-title":"Corneal Confocal Microscopy in Dry Eye Treated with Corticosteroids","volume":"92","author":"Villani","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib559","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/jop.2006.0091","article-title":"Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj\u00f6gren's syndrome","volume":"23","author":"Hong","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib560","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","article-title":"Locally administered ocular corticosteroids: benefits and risks","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.jtos.2017.05.006_bib561","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000336676","article-title":"The gold standard of noninfectious uveitis: corticosteroids","volume":"51","author":"LeHoang","year":"2012","journal-title":"Dev Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib562","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/bjo.2010.192773","article-title":"Do reducing regimens of fluorometholone for paediatric ocular surface disease cause glaucoma?","volume":"95","author":"Mataftsi","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib563","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000310839","article-title":"Fluorometholone-induced cataract after photorefractive keratectomy","volume":"211","author":"Bilgihan","year":"1997","journal-title":"Ophthalmologica"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib564","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12325-016-0315-8","article-title":"Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure","volume":"33","author":"Sheppard","year":"2016","journal-title":"Adv Ther"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib565","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/ICO.0b013e31818c69ef","article-title":"Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye","volume":"31","author":"Byun","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib566","doi-asserted-by":"crossref","first-page":"e26103","DOI":"10.1371\/journal.pone.0026103","article-title":"Corneal alternations induced by topical application of benzalkonium chloride in rabbit","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib567","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ICO.0000000000000695","article-title":"Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease","volume":"35","author":"Kim","year":"2016","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib568","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/FPC.0b013e328364db84","article-title":"PharmGKB summary: cyclosporine and tacrolimus pathways","volume":"23","author":"Barbarino","year":"2013","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib569","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","article-title":"Topical ophthalmic cyclosporine: pharmacology and clinical uses","volume":"54","author":"Donnenfeld","year":"2009","journal-title":"Surv Ophthalmol"},{"issue":"2\u20133","key":"10.1016\/j.jtos.2017.05.006_bib570","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib571","first-page":"CD005161","article-title":"Cyclosporin versus tacrolimus for liver transplanted patients","author":"Haddad","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib572","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/1098-2752(2000)20:8<420::AID-MICR13>3.0.CO;2-O","article-title":"Immunosuppressive agents in transplantation: mechanisms of action and current anti-rejection strategies","volume":"20","author":"Gorantla","year":"2000","journal-title":"Microsurgery"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2017.05.006_bib573","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.7869\/tg.179","article-title":"Cyclosporine in steroid refractory acute severe colitis","volume":"35","author":"Kumar","year":"2014","journal-title":"Trop Gastroenterol"},{"issue":"5 Suppl 35","key":"10.1016\/j.jtos.2017.05.006_bib574","first-page":"S101","article-title":"Benefit\/risk of cyclosporine in rheumatoid arthritis","volume":"22","author":"Gremese","year":"2004","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib575","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","article-title":"Clinical review: topical ophthalmic use of cyclosporin A","volume":"18","author":"Utine","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jtos.2017.05.006_bib576","doi-asserted-by":"crossref","first-page":"455","DOI":"10.17219\/acem\/37145","article-title":"Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial","volume":"23","author":"Keklikci","year":"2014","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.jtos.2017.05.006_bib577","first-page":"CD009078","article-title":"Topical cyclosporine for atopic keratoconjunctivitis","volume":"9","author":"Gonzalez-Lopez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib578","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.ophtha.2014.04.025","article-title":"Medically reversible limbal stem cell disease: clinical features and management strategies","volume":"121","author":"Kim","year":"2014","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib579","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","article-title":"Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes","volume":"118","author":"Kunert","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib580","first-page":"90","article-title":"Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A","volume":"42","author":"Brignole","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib581","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1167\/iovs.13-11681","article-title":"Mitochondrial permeability transition pore in inflammatory apoptosis of human conjunctival epithelial cells and T cells: effect of cyclosporin A","volume":"54","author":"Gao","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib582","first-page":"101","article-title":"Improvement of lacrimal function by topical application of CyA in murine models of Sj\u00f6gren's syndrome","volume":"42","author":"Tsubota","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib583","first-page":"1356","article-title":"Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes","volume":"41","author":"Brignole","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib584","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.ico.0000133994.22392.47","article-title":"Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca","volume":"24","author":"Strong","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib585","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/978-1-4615-5359-5_63","article-title":"Apoptosis in the lacrimal gland and conjunctiva of dry eye dogs","volume":"438","author":"Gao","year":"1998","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib586","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib587","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ICO.0b013e318158f6dc","article-title":"Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production","volume":"27","author":"Pflugfelder","year":"2008","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib588","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/bjo.2008.150011","article-title":"A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome","volume":"94","author":"Baiza-Dur\u00e1n","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib589","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/jop.2009.0145","article-title":"A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial","volume":"26","author":"Chen","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib590","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/ICO.0b013e318206caee","article-title":"The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy","volume":"30","author":"Su","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib591","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s10792-014-9901-4","article-title":"The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjogren's syndrome","volume":"34","author":"Deveci","year":"2014","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib592","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jcrs.2005.10.034","article-title":"Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis","volume":"32","author":"Salib","year":"2006","journal-title":"J Cataract Refract Surg"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib593","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/archopht.126.8.1046","article-title":"Evaluation of topical cyclosporine for the treatment of dry eye disease","volume":"126","author":"Perry","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib594","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jtos.2013.02.002","article-title":"Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies","volume":"11","author":"Alves","year":"2013","journal-title":"Ocul Surf"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib595","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bjophthalmol-2013-304072","article-title":"Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease","volume":"98","author":"Sacchetti","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib596","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/ICO.0000000000000123","article-title":"Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis","volume":"33","author":"Zhou","year":"2014","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib597","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","article-title":"Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis","volume":"13","author":"Wan","year":"2015","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib598","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archophthalmol.2008.608","article-title":"Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome","volume":"127","author":"Brown","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib599","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.ico.0000176611.88579.0a","article-title":"Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction","volume":"25","author":"Perry","year":"2006","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib600","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jop.2006.22.47","article-title":"Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis","volume":"22","author":"Rubin","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib601","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12325-009-0037-2","article-title":"Efficacy of topical cyclosporine for the treatment of ocular rosacea","volume":"26","author":"Schechter","year":"2009","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib602","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/jop.2012.0009","article-title":"Efficacy of cyclosporine 0.05% eye drops in Stevens Johnson syndrome with chronic dry eye","volume":"29","author":"Prabhasawat","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib603","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ophtha.2006.05.077","article-title":"Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment","volume":"114","author":"Wilson","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib604","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5301\/ejo.5000779","article-title":"Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial","volume":"26","author":"Leonardi","year":"2016","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib605","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.transproceed.2005.02.075","article-title":"Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters","volume":"37","author":"Takeuchi","year":"2005","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib606","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1089\/jop.2012.0265","article-title":"Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops","volume":"29","author":"Sanz-Marco","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib607","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.clae.2015.04.004","article-title":"Treatment of Sj\u00f6gren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study","volume":"38","author":"Moscovici","year":"2015","journal-title":"Cont Lens Anter Eye"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib608","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/ICO.0b013e31824988e5","article-title":"The effect of topical pranoprofen 0.1% on the clinical evaluation and conjunctival HLA-DR expression in dry eyes","volume":"31","author":"Liu","year":"2012","journal-title":"Cornea"},{"issue":"Pt B","key":"10.1016\/j.jtos.2017.05.006_bib609","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/978-1-4615-0717-8_177","article-title":"Topical non-preserved diclofenac therapy for keratoconjunctivitis sicca","volume":"506","author":"Rolando","year":"2002","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib610","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.eye.6701537","article-title":"Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sj\u00f6gren's syndrome patients","volume":"19","author":"Aragona","year":"2005","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib611","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/jop.2006.22.150","article-title":"Ketorolac during the induction phase of cyclosporin-A therapy","volume":"22","author":"Schechter","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2017.05.006_bib612","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1167\/iovs.13-13850","article-title":"Diclofenac protects cultured human corneal epithelial cells against hyperosmolarity and ameliorates corneal surface damage in a rat model of dry eye","volume":"55","author":"Sawazaki","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib613","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00003226-200003000-00005","article-title":"Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis","volume":"19","author":"Avisar","year":"2000","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib614","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jcrs.2007.04.041","article-title":"Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use","volume":"33","author":"Isawi","year":"2007","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib615","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/ICO.0000000000000309","article-title":"Topical NSAIDs effect on corneal sensitivity","volume":"34","author":"Singer","year":"2015","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib616","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1517\/14740338.6.1.33","article-title":"Is it safe to use topical NSAIDs for corneal sensitivity in Sj\u00f6gren's syndrome patients?","volume":"6","author":"Aragona","year":"2007","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib617","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/bj1610473","article-title":"The isolation and partial characterization of the major glycoprotein (LGP-I) from the articular lubricating fraction from bovine synovial fluid","volume":"161","author":"Swann","year":"1977","journal-title":"Biochem J"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib618","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/jamaophthalmol.2013.2385","article-title":"Transcription, translation, and function of lubricin, a boundary lubricant, at the ocular surface","volume":"131","author":"Schmidt","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib619","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/art.22446","article-title":"Boundary lubrication of articular cartilage: role of synovial fluid constituents","volume":"56","author":"Schmidt","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib620","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/bm400327a","article-title":"Synergistic interactions between grafted hyaluronic acid and lubricin provide enhanced wear protection and lubrication","volume":"14","author":"Das","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jtos.2017.05.006_bib621","doi-asserted-by":"crossref","first-page":"e0143415","DOI":"10.1371\/journal.pone.0143415","article-title":"Elastoviscous Transitions of Articular Cartilage Reveal a Mechanism of Synergy between Lubricin and Hyaluronic Acid","volume":"10","author":"Bonnevie","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2017.05.006_bib622","doi-asserted-by":"crossref","first-page":"18910","DOI":"10.1038\/srep18910","article-title":"Lubricin\/Proteoglycan 4 binds to and regulates the activity of Toll-Like Receptors In Vitro","volume":"6","author":"Iqbal","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2017.05.006_bib623","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13075-015-0877-x","article-title":"The interaction of lubricin\/proteoglycan 4 (PRG4) with toll-like receptors 2 and 4: an anti-inflammatory role of PRG4 in synovial fluid","volume":"17","author":"Alquraini","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib624","first-page":"1503","article-title":"Lubricin\/Proteoglycan 4 Binding to CD44 Receptor: A Mechanism of the Suppression of Proinflammatory Cytokine-Induced Synoviocyte Proliferation by Lubricin","volume":"67","author":"Al-Sharif","year":"2015"},{"key":"10.1016\/j.jtos.2017.05.006_bib625","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.exer.2014.06.015","article-title":"Characterization of full-length recombinant human Proteoglycan 4 as an ocular surface boundary lubricant","volume":"127","author":"Samsom","year":"2014","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib626","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jtos.2016.08.004","article-title":"A Two-Week, Randomized, Double-masked Study to Evaluate Safety and Efficacy of Lubricin (150 mug\/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed(R)) in Patients with Moderate Dry Eye Disease","volume":"15","author":"Lambiase","year":"2017","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib627","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ajo.2004.12.051","article-title":"Nerve growth factor concentration and implications in photorefractive keratectomy vs laser in situ keratomileusis","volume":"139","author":"Lee","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib628","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00417-009-1215-2","article-title":"Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy","volume":"248","author":"Yoon","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib629","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archophthalmol.2011.200","article-title":"Alterations of tear neuromediators in dry eye disease","volume":"129","author":"Lambiase","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib630","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0959-4388(00)00208-7","article-title":"Trk receptors: mediators of neurotrophin action","volume":"11","author":"Patapoutian","year":"2001","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib631","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1460-9568.1998.00037.x","article-title":"Corneal innervation and sensitivity to noxious stimuli in trkA knockout mice","volume":"10","author":"de Castro","year":"1998","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib632","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exer.2007.09.003","article-title":"Nerve growth factor and its receptor TrkA serve as potential markers for human corneal epithelial progenitor cells","volume":"86","author":"Qi","year":"2008","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib633","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00417-004-0955-2","article-title":"Efficacy of topical nerve growth factor treatment in dogs affected by dry eye","volume":"243","author":"Coassin","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib634","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.eye.6700616","article-title":"Neurotrophic keratitis","volume":"17","author":"Bonini","year":"2003","journal-title":"Eye (Lond)"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib635","first-page":"4584","article-title":"Effects of nerve growth factor on nerve regeneration after corneal nerve damage","volume":"7","author":"Ma","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib636","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.exer.2011.06.014","article-title":"An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eye","volume":"93","author":"Jain","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib637","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2147\/OPTH.S44688","article-title":"Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye","volume":"7","author":"Meerovitch","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib638","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jtos.2017.05.006_bib639","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/stem.708","article-title":"Action at a distance: systemically administered adult stem\/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-alpha stimulated gene\/protein 6","volume":"29","author":"Roddy","year":"2011","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib640","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","article-title":"Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-\u03baB signaling in resident macrophages","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib641","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1167\/iovs.14-14538","article-title":"TSG-6 protects corneal endothelium from transcorneal cryoinjury in rabbits","volume":"55","author":"Kim","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib642","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/ICO.0000000000000756","article-title":"Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye","volume":"35","author":"Kim","year":"2016","journal-title":"Cornea"},{"issue":"39","key":"10.1016\/j.jtos.2017.05.006_bib643","doi-asserted-by":"crossref","first-page":"16875","DOI":"10.1073\/pnas.1012451107","article-title":"Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury","volume":"107","author":"Oh","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2017.05.006_bib644","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1167\/iovs.14-16307","article-title":"Topical TSG-6 Administration Protects the Ocular Surface in Two Mouse Models of Inflammation-Related Dry Eye","volume":"56","author":"Lee","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib645","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.clinthera.2004.12.019","article-title":"Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis","volume":"26","author":"Furst","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.jtos.2017.05.006_bib646","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-2776(08)60535-0","article-title":"Interleukin-1 receptor antagonist","volume":"54","author":"Arend","year":"1993","journal-title":"Adv Immunol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib647","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-4835(02)00293-2","article-title":"Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury","volume":"76","author":"Yamada","year":"2003","journal-title":"Exp Eye Res"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib648","first-page":"3041","article-title":"Prevention of allergic eye disease by treatment with IL-1 receptor antagonist","volume":"40","author":"Keane-Myers","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib649","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1189\/jlb.0504280","article-title":"Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein","volume":"76","author":"Biswas","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib650","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.exer.2008.02.001","article-title":"Topical interleukin-1 receptor antagonist inhibits inflammatory cell infiltration into the cornea","volume":"86","author":"Stapleton","year":"2008","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib651","first-page":"1957","article-title":"Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease","volume":"19","author":"Vijmasi","year":"2013","journal-title":"Mol Vis"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib652","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamaophthalmol.2013.195","article-title":"Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial","volume":"131","author":"Amparo","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib653","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib654","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI117394","article-title":"Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor\/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis","volume":"94","author":"Cope","year":"1994","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib655","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","article-title":"Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj\u00f6gren's syndrome keratoconjunctivitis sicca","volume":"19","author":"Pflugfelder","year":"1999","journal-title":"Curr Eye Res"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib656","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","article-title":"Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome","volume":"26","author":"Yoon","year":"2007","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib657","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2008.08.032","article-title":"Tear cytokine profiles in dysfunctional tear syndrome","volume":"147","author":"Lam","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib658","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.20146","article-title":"Inefficacy of infliximab in primary Sj\u00f6gren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sj\u00f6gren's Syndrome (TRIPSS)","volume":"50","author":"Mariette","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib659","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.20299","article-title":"Etanercept in Sj\u00f6gren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial","volume":"50","author":"Sankar","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib660","first-page":"96","article-title":"Etanercept in the treatment of patients with primary Sj\u00f6gren's syndrome: a pilot study","volume":"31","author":"Zandbelt","year":"2004","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib661","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/ard.2007.077891","article-title":"Lack of efficacy of etanercept in Sj\u00f6gren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation","volume":"67","author":"Moutsopoulos","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2017.05.006_bib662","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/ICO.0b013e31826a80ea","article-title":"Effectiveness of topical infliximab in a mouse model of experimental dry eye","volume":"31","author":"Li","year":"2012","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib663","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1167\/iovs.12-11515","article-title":"Neutralization of ocular surface TNF-\u03b1 reduces ocular surface and lacrimal gland inflammation induced by in vivo dry eye","volume":"54","author":"Ji","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib664","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1167\/iovs.09-3838","article-title":"Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway","volume":"51","author":"Zheng","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib665","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/mi.2009.21","article-title":"Role of Th17 cells in the immunopathogenesis of dry eye disease","volume":"2","author":"Chauhan","year":"2009","journal-title":"Mucosal Immunol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib666","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mi.2009.5","article-title":"IL-17 disrupts corneal barrier following desiccating stress","volume":"2","author":"De Paiva","year":"2009","journal-title":"Mucosal Immunol"},{"issue":"17","key":"10.1016\/j.jtos.2017.05.006_bib667","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1182\/blood-2011-01-332049","article-title":"A novel pro-lymphangiogenic function for Th17\/IL-17","volume":"118","author":"Chauhan","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib668","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1358\/dnp.2008.21.3.1203413","article-title":"Therapeutic targets in dry eye syndrome","volume":"21","author":"Peral","year":"2008","journal-title":"Drug News Perspect"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib669","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1167\/iovs.11-8113","article-title":"Neurotransmitter influence on human meibomian gland epithelial cells","volume":"52","author":"Kam","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib670","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ICU.0b013e3283543b61","article-title":"Nerve growth factor therapy for corneal disease","volume":"23","author":"Lambiase","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib671","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7150\/thno\/v01p0154","article-title":"Integrin targeted therapeutics","volume":"1","author":"Millard","year":"2011","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib672","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(87)90104-8","article-title":"Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)","volume":"51","author":"Marlin","year":"1987","journal-title":"Cell"},{"issue":"5425","key":"10.1016\/j.jtos.2017.05.006_bib673","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.285.5425.221","article-title":"The immunological synapse: a molecular machine controlling T cell activation","volume":"285","author":"Grakoui","year":"1999","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib674","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/ml2002482","article-title":"Discovery and Development of Potent LFA-1\/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye","volume":"3","author":"Zhong","year":"2012","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib675","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/jop.2012.0102","article-title":"Corneal inflammation is inhibited by the LFA-1 antagonist, lifitegrast (SAR 1118)","volume":"29","author":"Sun","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib676","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jtos.2016.01.001","article-title":"Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease","volume":"14","author":"Perez","year":"2016","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib677","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ajo.2011.11.003","article-title":"A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye","volume":"153","author":"Semba","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib678","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ophtha.2013.09.015","article-title":"Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study","volume":"121","author":"Sheppard","year":"2014","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib679","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.ophtha.2015.08.001","article-title":"Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study","volume":"122","author":"Tauber","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2017.05.006_bib680","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/ICO.0000000000000803","article-title":"Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study","volume":"35","author":"Donnenfeld","year":"2016","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib681","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0014-4835(03)00005-8","article-title":"Minocycline effect on meibomian gland lipids in meibomianitis patients","volume":"76","author":"Shine","year":"2003","journal-title":"Exp Eye Res"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib682","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00003226-200308000-00011","article-title":"Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis","volume":"22","author":"Ta","year":"2003","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib683","first-page":"2970","article-title":"The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci","volume":"32","author":"Dougherty","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib684","first-page":"2544","article-title":"Doxycycline inhibition of interleukin-1 in the corneal epithelium","volume":"41","author":"Solomon","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib685","doi-asserted-by":"crossref","first-page":"C595","DOI":"10.1152\/ajpcell.2001.281.2.C595","article-title":"Rabbit conjunctival epithelium transports fluid, and P2Y2(2) receptor agonists stimulate Cl(-) and fluid secretion","volume":"281","author":"Li","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib686","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.exer.2005.08.019","article-title":"JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells","volume":"82","author":"Li","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib687","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1167\/iovs.13-13577","article-title":"Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model","volume":"55","author":"Zhang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib688","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ICO.0000000000000351","article-title":"Can tetracycline antibiotics duplicate the ability of azithromycin to stimulate human meibomian gland epithelial cell differentiation?","volume":"34","author":"Liu","year":"2015","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib689","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1128\/AAC.5.3.330","article-title":"Entry of four tetracyclines into saliva and tears","volume":"5","author":"Hoeprich","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib690","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0039-6257(96)80064-6","article-title":"Meibomian gland dysfunction","volume":"40","author":"Driver","year":"1996","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib691","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaad.2004.05.034","article-title":"Demodicosis and rosacea: epidemiology and significance in daily dermatologic practice","volume":"52","author":"Forton","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib692","first-page":"663","article-title":"The pathophysiology of rosacea","volume":"144","author":"Mc Aleer","year":"2009","journal-title":"G Ital Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib693","first-page":"21","article-title":"The potential role of microorganisms in the development of rosacea","volume":"9","author":"Lazaridou","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"issue":"Pt 11","key":"10.1016\/j.jtos.2017.05.006_bib694","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1099\/jmm.0.048090-0","article-title":"Potential role of Demodex mites and bacteria in the induction of rosacea","volume":"61","author":"Jarmuda","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jtos.2017.05.006_bib695","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1001\/jama.2015.15287","article-title":"Interventions for Rosacea","volume":"314","author":"van Zuuren","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jtos.2017.05.006_bib696","first-page":"CD003262","article-title":"Interventions for rosacea","volume":"4","author":"van Zuuren","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib697","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1167\/iovs.13-11863","article-title":"The influence of 13-cis retinoic acid on human meibomian gland epithelial cells","volume":"54","author":"Ding","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib698","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2133.1972.tb07416.x","article-title":"Perioral dermatitis: aetiology and treatment with tetracycline","volume":"87","author":"Macdonald","year":"1972","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib699","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/014107689709000308","article-title":"Rosacea: classification and treatment","volume":"90","author":"Jansen","year":"1997","journal-title":"J R Soc Med"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib700","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0002-9394(89)90676-4","article-title":"The effect of doxycycline on ocular rosacea","volume":"107","author":"Frucht-Pery","year":"1989","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib701","first-page":"904","article-title":"Treatment of ocular rosacea with 40 mg doxycycline in a slow release form","volume":"9","author":"Pfeffer","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib702","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bjo.79.1.42","article-title":"Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea","volume":"79","author":"Seal","year":"1995","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib703","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00417-005-0212-3","article-title":"Tear fluid levels of MMP-8 are elevated in ocular rosacea-treatment effect of oral doxycycline","volume":"244","author":"M\u00e4\u00e4tt\u00e4","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib704","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/1523-1747.ep12530797","article-title":"Hamster flank organ hydrolase and lipase activity","volume":"75","author":"Gulbenkian","year":"1980","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2017.05.006_bib705","first-page":"CD005556","article-title":"Interventions for chronic blepharitis","volume":"5","author":"Lindsley","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib706","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1345\/aph.1E282","article-title":"Use of macrolides and tetracyclines for chronic inflammatory diseases","volume":"39","author":"Voils","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib707","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjo.2006.091579","article-title":"Short term oral minocycline treatment of meibomianitis","volume":"90","author":"Aronowicz","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib708","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3341\/kjo.2005.19.4.258","article-title":"The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction","volume":"19","author":"Yoo","year":"2005","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib709","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-5751-6-11","article-title":"Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sj\u00f6gren's syndrome: a randomized, double-blind, placebo controlled cross-over study","volume":"6","author":"Seitsalo","year":"2007","journal-title":"J Negat Results Biomed"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib710","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ajo.2012.06.009","article-title":"Minocycline Controls Clinical Outcomes and Inflammatory Cytokines in Moderate and Severe Meibomian Gland Dysfunction","volume":"154","author":"Lee","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib711","first-page":"475","article-title":"The scientific context and basis of the pharmacologic management of dry eyes","volume":"18","author":"Gilbard","year":"2005","journal-title":"Ophthalmol Clin N Am"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib712","first-page":"118","article-title":"A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines","volume":"74","author":"Del Rosso","year":"2004","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib713","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jtos.2017.05.006_bib714","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.291.7.827","article-title":"Antibiotic use in relation to the risk of breast cancer","volume":"291","author":"Velicer","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib715","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10552-005-0445-9","article-title":"Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States)","volume":"17","author":"Velicer","year":"2006","journal-title":"Cancer Causes Control"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib716","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/aje\/kwi087","article-title":"Use of antibiotics and risk of breast cancer","volume":"161","author":"Garc\u00eda Rodr\u00edguez","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib717","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bjophthalmol-2014-305410","article-title":"Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double-masked open-label clinical trial","volume":"99","author":"Kashkouli","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib718","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamaophthalmol.2013.5295","article-title":"Oral azithromycin for the treatment of meibomitis","volume":"132","author":"Greene","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib719","first-page":"1797","article-title":"Emerging treatment options for meibomian gland dysfunction","volume":"7","author":"Qiao","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib720","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/ICO.0b013e318207fc42","article-title":"Oral azithromycin for treatment of posterior blepharitis","volume":"30","author":"Igami","year":"2011","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib721","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2009.03132.x","article-title":"Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin","volume":"23","author":"Bakar","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib722","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archderm.140.4.489","article-title":"Oral use of azithromycin for the treatment of acne rosacea","volume":"140","author":"Fernandez-Obregon","year":"2004","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib723","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-4632.2004.01958.x","article-title":"Therapeutic potential of azithromycin in rosacea","volume":"43","author":"Bakar","year":"2004","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib724","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijantimicag.2007.08.001","article-title":"Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators","volume":"31","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl B","key":"10.1016\/j.jtos.2017.05.006_bib725","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/41.suppl_2.37","volume":"41","author":"Labro","year":"1998","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 9A","key":"10.1016\/j.jtos.2017.05.006_bib726","first-page":"2S","article-title":"Immunomodulatory properties of macrolides: overview and historical perspective","volume":"117","author":"Rubin","year":"2004","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib727","first-page":"898","article-title":"Azithromycin as an alternative rosacea therapy when tetracyclines prove problematic","volume":"7","author":"Modi","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib728","first-page":"274","article-title":"Comparison of oral azithromycin pulse with daily doxycycline in the treatment of acne vulgaris","volume":"69","author":"Singhi","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib729","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/09546630701881506","article-title":"Azithromycin pulses in the treatment of inflammatory and pustular acne: efficacy, tolerability and safety","volume":"19","author":"Antonio","year":"2008","journal-title":"J Dermatol Treat"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib730","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s12325-008-0096-9","article-title":"Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis","volume":"25","author":"Luchs","year":"2008","journal-title":"Adv Ther"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib731","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/ICO.0b013e3181ca38a0","article-title":"Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis","volume":"29","author":"Haque","year":"2010","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib732","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1444-0938.2010.00540.x","article-title":"Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis","volume":"94","author":"Opitz","year":"2011","journal-title":"Clin Exp Optom"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib733","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/ICL.0b013e31823ff229","article-title":"Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye","volume":"38","author":"Nichols","year":"2012","journal-title":"Eye Contact Lens"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib734","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1590\/S0004-27492012000300006","article-title":"Azithromycin 1.5% ophthalmic solution: efficacy and treatment modalities in chronic blepharitis","volume":"75","author":"Fadlallah","year":"2012","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib735","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2147\/OPTH.S110739","volume":"10","author":"Hosseini","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib736","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/ICO.0b013e318254205f","article-title":"Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study","volume":"32","author":"Foulks","year":"2013","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib737","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ophtha.2015.10.062","article-title":"Oral Antibiotics for Meibomian Gland-Related Ocular Surface Disease: A Report by the American Academy of Ophthalmology","volume":"123","author":"Wladis","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib738","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0161-6420(88)33163-5","article-title":"Botulinum toxin A-induced protective ptosis in corneal disease","volume":"95","author":"Kirkness","year":"1988","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib739","first-page":"237","article-title":"Reversible suture tarsorrhaphy for eyelid malposition and keratopathy","volume":"22","author":"Gossman","year":"1991","journal-title":"Ophthalmic Surg"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib740","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1167\/iovs.14-16337","article-title":"The impact of conjunctivochalasis on dry eye symptoms and signs","volume":"56","author":"Chhadva","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib741","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.opx.0000232814.39651.fa","article-title":"The features of dry eye disease in a Japanese elderly population","volume":"83","author":"Uchino","year":"2006","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib742","first-page":"802","article-title":"Lid-parallel conjunctival folds are a sure diagnostic sign of dry eye","volume":"92","author":"Hoh","year":"1995","journal-title":"Ophthalmologe"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib743","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/bjophthalmol-2012-301580","article-title":"Lid-parallel conjunctival folds (LIPCOF) and dry eye: a multicentre study","volume":"96","author":"N\u00e9meth","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib744","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.ophtha.2013.01.007","article-title":"Conjunctivochalasis interferes with tear flow from fornix to tear meniscus","volume":"120","author":"Huang","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib745","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1167\/iovs.14-15908","article-title":"Impact of conjunctival folds on central tear meniscus height","volume":"56","author":"Pult","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib746","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00002341-198601040-00005","article-title":"Conjunctivochalasis, A cause of tearing and its management","volume":"2","author":"Liu","year":"1986","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib747","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/IOP.0b013e3182831dd3","article-title":"Medial conjunctival resection for tearing associated with conjunctivochalasis","volume":"29","author":"Petris","year":"2013","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.jtos.2017.05.006_bib748","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000131086","article-title":"Surgery of the conjunctiva","volume":"41","author":"Yokoi","year":"2008","journal-title":"Dev Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib749","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/ICO.0b013e3181dc81d2","article-title":"Thermocautery for inferior conjunctivochalasis","volume":"31","author":"Nakasato","year":"2012","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib750","doi-asserted-by":"crossref","first-page":"90","DOI":"10.9738\/CC59.1","article-title":"Electrocoagulative surgical procedure for treatment of conjunctivochalasis","volume":"97","author":"Zhang","year":"2012","journal-title":"Int Surg"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib751","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0002-9394(99)00384-0","article-title":"A new surgical technique for management of conjunctivochalasis","volume":"129","author":"Otaka","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib752","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/ICO.0b013e318255eaaa","article-title":"New approach for conjunctivochalasis using an argon green laser","volume":"32","author":"Yang","year":"2013","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib753","first-page":"67","article-title":"A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin","volume":"13","author":"Price","year":"1993","journal-title":"J Clin Neuroophthalmol"},{"issue":"Pt 4","key":"10.1016\/j.jtos.2017.05.006_bib754","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/eye.1988.79","article-title":"The significance of ophthalmological symptoms in idiopathic blepharospasm","volume":"2","author":"Elston","year":"1988","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib755","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","article-title":"Blepharospasm: a review of 264 patients","volume":"51","author":"Grandas","year":"1988","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib756","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ana.410130406","article-title":"Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients","volume":"13","author":"Jankovic","year":"1983","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib757","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ajo.2013.11.014","article-title":"The influence of benign essential blepharospasm on dry eye disease and ocular inflammation","volume":"157","author":"Lu","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib758","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1111\/aos.12002","article-title":"Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm","volume":"91","author":"Park","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib759","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9394(99)00408-0","article-title":"Effect of eyelid botulinum toxin injection on lacrimal drainage","volume":"129","author":"Sahlin","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib760","doi-asserted-by":"crossref","first-page":"830","DOI":"10.5301\/ejo.5000482","article-title":"Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection","volume":"24","author":"Kocabeyoglu","year":"2014","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib761","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/bjo.87.1.54","article-title":"Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye","volume":"87","author":"Horwath-Winter","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib762","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000131089","article-title":"Eyelid botulinum toxin injections for the dry eye","volume":"41","author":"Sahlin","year":"2008","journal-title":"Dev Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib763","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0002-9394(14)73926-1","article-title":"Dermatochalasis and dry eye","volume":"115","author":"Vold","year":"1993","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib764","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1034\/j.1600-0420.2003.00064.x","article-title":"A conservative blepharoplasty may be a means of alleviating dry eye symptoms","volume":"81","author":"Floegel","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib765","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/01676830.2014.881889","article-title":"Is dry eye associated with acquired aponeurogenic blepharoptosis?","volume":"33","author":"Moesen","year":"2014","journal-title":"Orbit"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib766","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/01676830.2014.982766","article-title":"Tear condition following unilateral ptosis surgery","volume":"34","author":"Bagheri","year":"2015","journal-title":"Orbit"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib767","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/ICO.0000000000000010","article-title":"Short-term changes in tear volume after blepharoptosis repair","volume":"33","author":"Watanabe","year":"2014","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib768","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1167\/iovs.14-15632","article-title":"Long-term Tear Volume Changes After Blepharoptosis Surgery and Blepharoplasty","volume":"56","author":"Watanabe","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib769","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/2013.jamafacial.1","article-title":"Dry eye symptoms and chemosis following blepharoplasty: a 10-year retrospective review of 892 cases in a single-surgeon series","volume":"15","author":"Prischmann","year":"2013","journal-title":"JAMA Facial Plast Surg"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib770","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-0033-1349362","article-title":"Complications of blepharoplasty","volume":"29","author":"Leatherbarrow","year":"2013","journal-title":"Facial Plast Surg"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib771","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajo.2014.03.016","article-title":"Dynamic Changes of Tear Fluid After Cosmetic Transcutaneous Lower Blepharoplasty Measured by Optical Coherence Tomography","volume":"158","author":"Shao","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib772","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/PRS.0b013e3181c830c7","article-title":"Minor complications after blepharoplasty: dry eyes, chemosis, granulomas, ptosis, and scleral show","volume":"125","author":"Pacella","year":"2010","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib773","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0161-6420(00)00026-9","article-title":"Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome","volume":"107","author":"Honavar","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2017.05.006_bib774","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0161-6420(99)90022-2","article-title":"Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid","volume":"106","author":"Donnenfeld","year":"1999","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib775","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0161-6420(02)01892-4","article-title":"Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid","volume":"110","author":"Barabino","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2017.05.006_bib776","first-page":"CD011349","article-title":"Conjunctival autograft for pterygium","volume":"2","author":"Clearfield","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib777","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ophtha.2012.06.066","article-title":"Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology","volume":"120","author":"Kaufman","year":"2013","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib778","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00130832-200410000-00017","article-title":"Ocular cicatricial pemphigoid review","volume":"4","author":"Foster","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib779","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.survophthal.2009.03.004","article-title":"Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"54","author":"Shay","year":"2009","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib780","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3126\/nepjoph.v2i2.3722","article-title":"Role of amniotic membrane transplantation in ocular surface disorders","volume":"2","author":"Arya","year":"2010","journal-title":"Nepal J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib781","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ophtha.2011.01.046","article-title":"Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases","volume":"118","author":"Gregory","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib782","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jtos.2015.07.003","article-title":"Accelerated Restoration of Ocular Surface Health in Dry Eye Disease by Self-Retained Cryopreserved Amniotic Membrane","volume":"14","author":"Cheng","year":"2016","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib783","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(99)00016-6","article-title":"Evidence for the presence of dopamine D1 receptor mRNA and binding sites in monkey amniotic epithelial cells","volume":"262","author":"Elwan","year":"1999","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib784","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1097-4547(19980701)53:1<107::AID-JNR11>3.0.CO;2-6","article-title":"Synthesis and release of catecholamines by cultured monkey amniotic epithelial cells","volume":"53","author":"Elwan","year":"1998","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib785","first-page":"875","article-title":"Neurotrophic Effect of Amniotic Membrane on Neuronal Cell Cultures: An in vitro Model to Study Underlying Action Mechanisms of Amniotic Membrane in the Treatment of Neurotrophic Keratopathy","volume":"46","author":"Meller","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib786","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1254\/jjp.85.20","article-title":"Non-neuronal neurotransmitters and neurotrophic factors in amniotic epithelial cells: expression and function in humans and monkey","volume":"85","author":"Sakuragawa","year":"2001","journal-title":"Jpn J Pharmacol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib787","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00006534-200001000-00024","article-title":"Nerve dependency in scarless fetal wound healing","volume":"105","author":"Stelnicki","year":"2000","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jtos.2017.05.006_bib788","first-page":"23","article-title":"Insert and remove and amniotic membrane graft","volume":"152","author":"Ryff","year":"2015","journal-title":"Rev Optom"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib789","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/ICL.0b013e3182a2f8fa","article-title":"Sutureless amniotic membrane ProKera for ocular surface disorders: short-term results","volume":"39","author":"Suri","year":"2013","journal-title":"Eye Contact Lens"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib790","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1097\/ICL.0b013e318255124f","article-title":"Placement of ProKera in the management of ocular manifestations of acute Stevens-Johnson syndrome in an outpatient","volume":"39","author":"Kolomeyer","year":"2013","journal-title":"Eye Contact Lens"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib791","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ajo.2004.08.051","article-title":"Experimental study of an automated system for the delivery of eyedrops using a microinfusion pump","volume":"139","author":"Kwon","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib792","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1076\/orbi.22.1.29.14012","article-title":"Subcutaneous abdominal artificial tears pump-reservoir for severe dry eye","volume":"22","author":"Murube","year":"2003","journal-title":"Orbit"},{"key":"10.1016\/j.jtos.2017.05.006_bib793","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000131095","article-title":"Mechanical pump dacryoreservoirs","volume":"41","author":"Murube","year":"2008","journal-title":"Dev Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib794","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s004170050008","article-title":"Quality of salivary tears following autologous submandibular gland transplantation for severe dry eye","volume":"238","author":"Geerling","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib795","first-page":"104","article-title":"Labial Salivary Gland Transplantation in Severe Dry Eye","volume":"2","author":"Murube","year":"1998","journal-title":"Oper Tech Oculoplast Orbital Reconstr Surg"},{"key":"10.1016\/j.jtos.2017.05.006_bib796","first-page":"131","article-title":"Surgical Treatment of Parenchymatous Opthalmoxerosis","volume":"3","author":"Filatov","year":"1951","journal-title":"J Oftalmol Odessa"},{"key":"10.1016\/j.jtos.2017.05.006_bib797","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000131094","article-title":"Transplantation of the major salivary glands","volume":"41","author":"Geerling","year":"2008","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib798","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/15027732.1986.12461426","article-title":"Transplantation of salivary gland to the lacrimal basin","volume":"61","author":"Murube-del-Castillo","year":"1986","journal-title":"Scand J Rheumatol Suppl"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib799","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/bjophthalmol-2013-303280","article-title":"Microvascular autologous transplantation of partial submandibular gland for severe keratoconjunctivitis sicca","volume":"97","author":"Qin","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib800","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.tp.0000296060.39823.a4","article-title":"Innervation and secretory function of transplanted human submandibular salivary glands","volume":"85","author":"Geerling","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jtos.2017.05.006_bib801","first-page":"45","article-title":"Experimental approach to surgical treatment of lacrimal insufficiency by microvascular submandibular salivary gland autotransplantation","volume":"245","author":"Lasudry","year":"1992","journal-title":"Bull Soc Belge Ophtalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib802","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0007-1226(90)90008-N","article-title":"Microvascular submandibular gland transfer for the management of xerophthalmia; an experimental study","volume":"43","author":"Kumar","year":"1990","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.jtos.2017.05.006_bib803","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/978-1-4615-2417-5_96","article-title":"Amylase in mare lacrimale in patients with submandibular salivary gland transplantation to the lacrimal basin","volume":"350","author":"Murube","year":"1994","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib804","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1442-9071.1992.tb00719.x","article-title":"Submandibular gland transfer in the correction of dry eye","volume":"20","author":"MacLeod","year":"1992","journal-title":"Aust N. Z J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib805","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0161-6420(98)93406-6","article-title":"Transplantation of the autologous submandibular gland for most severe cases of keratoconjunctivitis sicca","volume":"105","author":"Geerling","year":"1998","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib806","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.mlg.0000246953.44163.81","article-title":"Submandibular gland transfer for severe xerophthalmia","volume":"117","author":"Paniello","year":"2007","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib807","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ajo.2010.05.010","article-title":"Long-term follow-up after submandibular gland transplantation in severe dry eyes secondary to cicatrizing conjunctivitis","volume":"150","author":"Borrelli","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib808","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s002590050204","article-title":"Salivary gland scintigraphy using technetium-99m-pertechnetate after autotransplantation of the submandibular salivary gland in the correction of dry eye","volume":"25","author":"Lauer","year":"1998","journal-title":"Eur J Nucl Med"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib809","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jcms.2013.01.015","article-title":"Allogenic submandibular gland transplantation following hematopoietic stem cell transplantation","volume":"41","author":"Jacobsen","year":"2013","journal-title":"J Craniomaxillofac Surg"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib810","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/bjo.86.1.43","article-title":"Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation","volume":"86","author":"Keegan","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib811","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jtos.2014.04.001","article-title":"A new treatment for epiphora secondary to submandibular gland transplantation: transcutaneous atropine gel","volume":"12","author":"Cai","year":"2014","journal-title":"Ocul Surf"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib812","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.ico.0000225718.93006.44","article-title":"Novel technique to control hypersecretion from a transplanted autologous submandibular salivary gland for keratoconjunctivitis sicca","volume":"25","author":"Leibovitch","year":"2006","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib813","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bbapap.2012.01.011","article-title":"Proteomic analysis of secretion from human transplanted submandibular gland replacing lacrimal gland with severe keratoconjunctivitis sicca","volume":"1824","author":"Song","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib814","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/bjo.84.3.279","article-title":"Long term results after autologous nasal mucosal transplantation in severe mucus deficiency syndromes","volume":"84","author":"Wenkel","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib815","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-0420.1996.tb00596.x","article-title":"Autologous transplantation of nasal mucosa after severe chemical and thermal eye burns","volume":"74","author":"Kuckelkorn","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib816","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.archoralbio.2014.11.016","article-title":"Characteristics of the saliva flow rates of minor salivary glands in healthy people","volume":"60","author":"Wang","year":"2015","journal-title":"Arch Oral Biol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib817","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/IOP.0b013e3181b8c3ad","article-title":"Labial salivary gland transplantation for severe dry eye due to chemical burns and Stevens-Johnson syndrome","volume":"26","author":"Marinho","year":"2010","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib818","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/bjo.2010.199901","article-title":"Minor salivary glands and labial mucous membrane graft in the treatment of severe symblepharon and dry eye in patients with Stevens-Johnson syndrome","volume":"96","author":"Sant' Anna","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib819","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1249\/MSS.0b013e31820e7cb6","article-title":"Tear fluid osmolarity as a potential marker of hydration status","volume":"43","author":"Fortes","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jtos.2017.05.006_bib820","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/ICO.0b013e31821ddd3a","article-title":"Influence of modest changes in whole-body hydration on tear fluid osmolarity: important considerations for dry eye disease detection","volume":"30","author":"Walsh","year":"2011","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib821","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1167\/iovs.12-10175","article-title":"Is whole-body hydration an important consideration in dry eye?","volume":"53","author":"Walsh","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib822","first-page":"1","article-title":"Omega-6\/omega-3 essential fatty acids: biological effects","volume":"99","author":"Simopoulos","year":"2009","journal-title":"World Rev Nutr Diet"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib823","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MCO.0b013e3283357242","article-title":"Omega-6 and omega-3 fatty acids: partners in prevention","volume":"13","author":"Harris","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib824","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11745-003-1068-y","article-title":"N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic","volume":"38","author":"Calder","year":"2003","journal-title":"Lipids"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib825","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Resolvins and protectins in inflammation resolution","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem Rev"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib826","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12035-010-8162-0","article-title":"Evolutionary aspects of diet: the omega-6\/omega-3 ratio and the brain","volume":"44","author":"Simopoulos","year":"2011","journal-title":"Mol Neurobiol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib827","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0753-3322(02)00253-6","article-title":"The importance of the ratio of omega-6\/omega-3 essential fatty acids","volume":"56","author":"Simopoulos","year":"2002","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib828","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198902023200501","article-title":"The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells","volume":"320","author":"Endres","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtos.2017.05.006_bib829","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jn\/121.4.547","article-title":"Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women","volume":"121","author":"Meydani","year":"1991","journal-title":"J Nutr"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib830","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jaut.2006.03.003","article-title":"N-3 fatty acids modulate Th1 and Th2 dichotomy in diabetic pregnancy and macrosomia","volume":"26","author":"Khan","year":"2006","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib831","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2567.1997.d01-2308.x","article-title":"Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids","volume":"92","author":"Purasiri","year":"1997","journal-title":"Immunology"},{"issue":"5\u20136","key":"10.1016\/j.jtos.2017.05.006_bib832","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0952-3278(99)80015-5","article-title":"Human peripheral blood T lymphocyte proliferation after activation of the T cell receptor: effects of unsaturated fatty acids","volume":"60","author":"Zurier","year":"1999","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jtos.2017.05.006_bib833","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.exer.2015.08.024","article-title":"In vitro effects of docosahexaenoic and eicosapentaenoic acid on human meibomian gland epithelial cells","volume":"140","author":"Hampel","year":"2015","journal-title":"Exp Eye Res"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib834","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/ICO.0000000000000874","article-title":"Influence of Omega 3 and 6 Fatty Acids on Human Meibomian Gland Epithelial Cells","volume":"35","author":"Liu","year":"2016","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib835","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000217726","article-title":"Nutrition for the eye: different susceptibility of the retina and the lacrimal gland to dietary omega-6 and omega-3 polyunsaturated fatty acid incorporation","volume":"41","author":"Schnebelen","year":"2009","journal-title":"Ophthalmic Res"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib836","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00417-009-1080-z","article-title":"Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model","volume":"247","author":"Viau","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib837","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archophthalmol.2007.61","article-title":"Topical omega-3 and omega-6 fatty acids for treatment of dry eye","volume":"126","author":"Rashid","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib838","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/02713683.2014.884595","article-title":"Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye","volume":"39","author":"Li","year":"2014","journal-title":"Curr Eye Res"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib839","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.1000833","article-title":"Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation","volume":"186","author":"Dartt","year":"2011","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib840","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-9255-11-6","article-title":"Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study","volume":"11","author":"Erdinest","year":"2014","journal-title":"J Inflamm (Lond)"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib841","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/jop.2010.0019","article-title":"Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model","volume":"26","author":"Li","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib842","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/ICO.0b013e31823f789e","article-title":"Resolvin E1 (RX-10001) Reduces Corneal Epithelial Barrier Disruption and Protects Against Goblet Cell Loss in a Murine Model of Dry Eye","volume":"31","author":"de Paiva","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib843","first-page":"1710","article-title":"Resolvin E1 analog RX-10045 0.1% reduces corneal stromal haze in rabbits when applied topically after PRK","volume":"20","author":"Torricelli","year":"2014","journal-title":"Mol Vis"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib844","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1167\/iovs.09-3641","article-title":"Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA","volume":"51","author":"Cortina","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib845","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archophthalmol.2011.287","article-title":"Recovery of corneal sensitivity, calcitonin gene-related peptide-positive nerves, and increased wound healing induced by pigment epithelial-derived factor plus docosahexaenoic acid after experimental surgery","volume":"130","author":"Cortina","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib846","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ajcn\/82.4.887","article-title":"Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women","volume":"82","author":"Miljanovic","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib847","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1167\/iovs.16-19131","article-title":"\u03c9-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye","volume":"57","author":"Walter","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt A","key":"10.1016\/j.jtos.2017.05.006_bib848","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/978-1-4615-0717-8_62","article-title":"Correlations between nutrient intake and the polar lipid profiles of meibomian gland secretions in women with Sj\u00f6gren's syndrome","volume":"506","author":"Sullivan","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtos.2017.05.006_bib849","first-page":"336","article-title":"The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)","volume":"106","author":"Macsai","year":"2008","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib850","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/ICO.0b013e3181f22e03","article-title":"Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye","volume":"30","author":"Wojtowicz","year":"2011","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib851","first-page":"811","article-title":"A randomized controlled trial of omega-3 fatty acids in dry eye syndrome","volume":"6","author":"Bhargava","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib852","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2147\/CIA.S48955","article-title":"A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction","volume":"8","author":"Ole\u00f1ik","year":"2013","journal-title":"Clin Interv Aging"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib853","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2220\/biomedres.34.215","article-title":"Effects of dietary supplementation with fish oil on dry eye syndrome subjects: randomized controlled trial","volume":"34","author":"Kawakita","year":"2013","journal-title":"Biomed Res"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib854","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.ophtha.2013.04.006","article-title":"Short-term consumption of oral omega-3 and dry eye syndrome","volume":"120","author":"Kangari","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2017.05.006_bib855","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/CIA.S40640","article-title":"Effects of a nutraceutical formulation based on the combination of antioxidants and \u03c9-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders","volume":"8","author":"Pinazo-Dur\u00e1n","year":"2013","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jtos.2017.05.006_bib856","first-page":"169","article-title":"Effectiveness and tolerability of dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment of dry eye symptoms: results of a prospective study","volume":"8","author":"Ole\u00f1ik","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib857","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/ICL.0000000000000179","article-title":"Short-Term Omega 3 Fatty Acids Treatment for Dry Eye in Young and Middle-Aged Visual Display Terminal Users","volume":"42","author":"Bhargava","year":"2016","journal-title":"Eye Contact Lens"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib858","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2016.09.023","article-title":"A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease","volume":"124","author":"Deinema","year":"2017","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib859","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/ICO.0000000000000940","article-title":"Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes","volume":"35","author":"Epitropoulos","year":"2016","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib860","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/opo.12365","article-title":"Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study","volume":"37","author":"Chinnery","year":"2017","journal-title":"Ophthalmic Physiol Opt."},{"key":"10.1016\/j.jtos.2017.05.006_bib861","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.12659\/MSM.891364","article-title":"Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies","volume":"20","author":"Liu","year":"2014","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib862","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1345\/aph.1D007","article-title":"Fish oil interaction with warfarin","volume":"38","author":"Buckley","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jtos.2017.05.006_bib863","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clae.2009.11.002","article-title":"Essential fatty acids for dry eye: A review","volume":"33","author":"Roncone","year":"2010","journal-title":"Cont Lens Anter Eye"},{"issue":"15","key":"10.1016\/j.jtos.2017.05.006_bib864","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/jnci\/djt174","article-title":"Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial","volume":"105","author":"Brasky","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtos.2017.05.006_bib865","doi-asserted-by":"crossref","first-page":"dju015","DOI":"10.1093\/jnci\/dju015","article-title":"RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial","volume":"106","author":"Brenna","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib866","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3945\/ajcn.2010.29530","article-title":"Fish consumption and prostate cancer risk: a review and meta-analysis","volume":"92","author":"Szymanski","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib867","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00541208","article-title":"Primary Sj\u00f6gren's syndrome treated with Efamol\/Efavit. A double-blind cross-over investigation","volume":"4","author":"Manthorpe","year":"1984","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib868","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/03009748609102073","article-title":"Patients with primary Sj\u00f6gren's syndrome treated for two months with evening primrose oil","volume":"15","author":"Oxholm","year":"1986","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib869","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/03009740252937577","article-title":"Gammalinolenic acid treatment of fatigue associated with primary Sj\u00f6gren's syndrome","volume":"31","author":"Theander","year":"2002","journal-title":"Scand J Rheumatol"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib870","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1167\/iovs.04-1394","article-title":"Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sj\u00f6gren's syndrome patients","volume":"46","author":"Aragona","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib871","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/ICO.0b013e318033d79b","article-title":"Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction","volume":"26","author":"Pinna","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib872","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0181-5512(06)70106-1","article-title":"Improvement of dry eye symptoms with polyunsaturated fatty acids","volume":"29","author":"Creuzot","year":"2006","journal-title":"J Fr Ophtalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib873","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3945\/jn.109.118901","article-title":"Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye","volume":"140","author":"Larmo","year":"2010","journal-title":"J Nutr"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib874","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1111\/j.1755-3768.2011.02196.x","article-title":"A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients","volume":"89","author":"Brignole-Baudouin","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib875","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2147\/OPTH.S22647","article-title":"Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine A","volume":"5","author":"Jackson","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib876","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jfo.2011.01.018","article-title":"Efficacy assessment of Nutrilarm(R), a per os omega-3 and omega-6 polyunsaturated essential fatty acid dietary formulation versus placebo in patients with bilateral treated moderate dry eye syndrome","volume":"34","author":"Creuzot-Garcher","year":"2011","journal-title":"J Fr Ophtalmol"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib877","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/ICO.0b013e318299549c","article-title":"Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical Trial","volume":"32","author":"Sheppard","year":"2013","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib878","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/nure.12145","article-title":"Efficacy of polyunsaturated fatty acids for dry eye syndrome: a meta-analysis of randomized controlled trials","volume":"72","author":"Zhu","year":"2014","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jtos.2017.05.006_bib879","first-page":"CD011016","article-title":"Omega-3 and omega-6 polyunsaturated fatty acids for dry eye syndrome (Protocol)","volume":"3","author":"Ng","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib880","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/1573412911309040002","article-title":"Total Serum Fatty Acid Analysis by GC-MS: Assay Validation and Serum Sample Stability","volume":"9","author":"Ren","year":"2013","journal-title":"Curr Pharm Anal"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib881","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1755-3768.1994.tb02791.x","article-title":"Ocular surface damage and tear lactoferrin in dry eye syndrome","volume":"72","author":"Danjo","year":"1994","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2017.05.006_bib882","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00142704","article-title":"Analysis of human tear protein profiles using high performance liquid chromatography (HPLC)","volume":"67","author":"Boukes","year":"1987","journal-title":"Doc Ophthalmol"},{"issue":"Pt 4","key":"10.1016\/j.jtos.2017.05.006_bib883","first-page":"355","article-title":"The effect of ageing and disease on tear constituents","volume":"104","author":"Seal","year":"1985","journal-title":"Trans Ophthalmol Soc U K"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib884","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bjo.68.5.321","article-title":"Diagnostic implications of tear protein profiles","volume":"68","author":"Mackie","year":"1984","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib885","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9394(88)90587-9","article-title":"Diagnostic tests in patients with symptoms of keratoconjunctivitis sicca","volume":"106","author":"Goren","year":"1988","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib886","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/eye.2010.7","article-title":"Tear proteomics in evaporative dry eye disease","volume":"24","author":"Versura","year":"2010","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jtos.2017.05.006_bib887","doi-asserted-by":"crossref","first-page":"e33148","DOI":"10.1371\/journal.pone.0033148","article-title":"Dietary lactoferrin alleviates age-related lacrimal gland dysfunction in mice","volume":"7","author":"Kawashima","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jtos.2017.05.006_bib888","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.ophtha.2007.06.027","article-title":"Lactoferrin in Sj\u00f6gren's syndrome","volume":"114","author":"Dogru","year":"2007","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.jtos.2017.05.006_bib889","first-page":"NC06","article-title":"Effect of Oral Lactoferrin on Cataract Surgery Induced Dry Eye: A Randomised Controlled Trial","volume":"9","author":"Devendra","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"supp1","key":"10.1016\/j.jtos.2017.05.006_bib890","article-title":"The role of oxidative stress and inflammation in dry eye disease","volume":"28","author":"Dogru","year":"2009","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib891","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.ejcn.1601186","article-title":"Oral antioxidant therapy for marginal dry eye","volume":"55","author":"Blades","year":"2001","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib892","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/112067210901900302","article-title":"Antioxidants intake and dry eye syndrome: a crossover, placebo-controlled, randomized trial","volume":"19","author":"Drouault-Holowacz","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib893","first-page":"1","article-title":"MaquiBright standardized maqui berry extract significantly increases tear fluid production and ameliorates dry eye-related symptoms in a clinical pilot trial","volume":"56","author":"Hitoe","year":"2014","journal-title":"Panminerva Med"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib894","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.mehy.2005.07.020","article-title":"Pro-oxidant actions of alpha-lipoic acid and dihydrolipoic acid","volume":"66","author":"Cakatay","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jtos.2017.05.006_bib895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2013.12.014","article-title":"Alpha-lipoic acid restores tear production in an animal model of dry eye","volume":"120","author":"Andrade","year":"2014","journal-title":"Exp Eye Res"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2017.05.006_bib896","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/ICO.0b013e318228167f","article-title":"Effect of calorie restriction on change in lacrimal gland with age","volume":"30","author":"Kawashima","year":"2011","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib897","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jtos.2015.12.005","article-title":"Dietary Supplementation with a Combination of Lactoferrin, Fish Oil, and Enterococcus faecium WB2000 for Treating Dry Eye: A Rat Model and Human Clinical Study","volume":"14","author":"Kawashima","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2017.05.006_bib898","doi-asserted-by":"crossref","DOI":"10.1097\/ICL.0000000000000275","article-title":"Possible Association Between Dry Eye Symptoms and Body Fat: A Prospective, Cross-Sectional Preliminary Study","author":"Ho","year":"2017","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib899","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ophtha.2011.11.015","article-title":"Oral alcohol administration disturbs tear film and ocular surface","volume":"119","author":"Kim","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2017.05.006_bib900","doi-asserted-by":"crossref","first-page":"e0139761","DOI":"10.1371\/journal.pone.0139761","article-title":"Clinical Effect of Antioxidant Glasses Containing Extracts of Medicinal Plants in Patients with Dry Eye Disease: A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial","volume":"10","author":"Choi","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib901","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib902","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/112067210701700311","article-title":"Ocular symptoms and signs with preserved and preservative-free glaucoma medications","volume":"17","author":"Jaenen","year":"2007","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib903","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung","year":"2008","journal-title":"J Glaucoma"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib904","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00417-008-0881-9","article-title":"German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye","volume":"246","author":"Erb","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib905","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","article-title":"Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications","volume":"29","author":"Fechtner","year":"2010","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib906","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5301\/ejo.5000220","article-title":"Risk factors to develop ocular surface disease \u2028in treated glaucoma or ocular hypertension patients","volume":"23","author":"Rossi","year":"2013","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib907","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1097\/OPX.0000000000000667","article-title":"Association between Glaucoma Medication Usage and Dry Eye in Taiwan","volume":"92","author":"Chen","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib908","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1089\/jop.2013.0216","article-title":"Ocular surface changes in glaucomatous patients treated with and without preservatives beta-blockers","volume":"30","author":"Iester","year":"2014","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2017.05.006_bib909","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/112067210801800314","article-title":"An in vivo confocal microscopy and impression cytology analysis of preserved and unpreserved levobunolol-induced conjunctival changes","volume":"18","author":"Ciancaglini","year":"2008","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib910","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/jop.2010.0060","article-title":"Efficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patients","volume":"26","author":"Renieri","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib911","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1755-3768.2010.01907.x","article-title":"Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication","volume":"88","author":"Uusitalo","year":"2010","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib912","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/17469899.4.1.59","article-title":"Preservatives in topical ophthalmic medications: historical and clinical perspectives","volume":"4","author":"Freeman","year":"2009","journal-title":"Expert Rev Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib913","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/jop.2006.22.267","article-title":"Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study","volume":"22","author":"Labb\u00e9","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib914","first-page":"613","article-title":"Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapy","volume":"2","author":"Henry","year":"2008","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib915","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2147\/OPTH.S14113","article-title":"Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost","volume":"4","author":"Katz","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib916","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/j.1755-3768.2012.02565.x","article-title":"Effects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface \u2013 a multicentre randomized single-masked study","volume":"91","author":"Aihara","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib917","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1542-0124(11)70034-9","article-title":"Non-hormonal systemic medications and dry eye","volume":"9","author":"Wong","year":"2011","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib918","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jtos.2014.01.006","article-title":"The precorneal tear film as a fluid shell: the effect of blinking and saccades on tear film distribution and dynamics","volume":"12","author":"Yokoi","year":"2014","journal-title":"Ocul Surf"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib919","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199302253280817","article-title":"Dry eyes and video display terminals","volume":"328","author":"Tsubota","year":"1993","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib920","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archopht.1995.01100020037025","article-title":"Effects of ocular surface area and blink rate on tear dynamics","volume":"113","author":"Tsubota","year":"1995","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib921","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ajo.2013.05.040","article-title":"Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study","volume":"156","author":"Uchino","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib922","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib923","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.ophtha.2008.06.022","article-title":"Prevalence of dry eye disease among Japanese visual display terminal users","volume":"115","author":"Uchino","year":"2008","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib924","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.eye.6703025","article-title":"Meibomian gland dysfunction and ocular discomfort in video display terminal workers","volume":"22","author":"Fenga","year":"2008","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jtos.2017.05.006_bib925","doi-asserted-by":"crossref","first-page":"e105575","DOI":"10.1371\/journal.pone.0105575","article-title":"Meibomian gland dysfunction determines the severity of the dry eye conditions in visual display terminal workers","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib926","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jamaophthalmol.2014.1008","article-title":"Alteration of tear mucin 5AC in office workers using visual display terminals: The Osaka Study","volume":"132","author":"Uchino","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib927","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1167\/iovs.06-1027","article-title":"Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye","volume":"48","author":"Nakamura","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib928","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/bjophthalmol-2012-302695","article-title":"Effect of a light-emitting timer device on the blink rate of non-dry eye individuals and dry eye patients","volume":"97","author":"Miura","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib929","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clae.2014.05.005","article-title":"Effects of transient blur and VDT screen luminance changes on eyeblink rate","volume":"37","author":"Cardona","year":"2014","journal-title":"Cont Lens Anter Eye"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib930","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.survophthal.2005.02.008","article-title":"Computer vision syndrome: a review","volume":"50","author":"Blehm","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib931","first-page":"121","article-title":"Impact of evaporation on aqueous tear loss","volume":"104","author":"McCulley","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib932","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/ICO.0b013e31826671ab","article-title":"The effect of low humidity on the human tear film","volume":"32","author":"Abusharha","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib933","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1167\/iovs.12-11322","article-title":"Factors predicting the ocular surface response to desiccating environmental stress","volume":"54","author":"Alex","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib934","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ajo.2014.01.001","article-title":"Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions","volume":"157","author":"L\u00f3pez-Miguel","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib935","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2015.09.039","article-title":"Clinical and Molecular Inflammatory Response in Sjogren Syndrome-Associated Dry Eye Patients Under Desiccating Stress","volume":"161","author":"Lopez-Miguel","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib936","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/jop.2013.0050","article-title":"Effect of hypotonic 0.18% sodium hyaluronate eyedrops on inflammation of the ocular surface in experimental dry eye","volume":"30","author":"Oh","year":"2014","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2017.05.006_bib937","doi-asserted-by":"crossref","first-page":"292139","DOI":"10.1155\/2014\/292139","article-title":"Trehalose-based eye drops preserve viability and functionality of cultured human corneal epithelial cells during desiccation","volume":"2014","author":"Hill-Bator","year":"2014","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib938","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajo.2015.04.008","article-title":"Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease","volume":"160","author":"Moore","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib939","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1167\/iovs.12-11216","article-title":"The CCR6\/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease","volume":"54","author":"Dohlman","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib940","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/archophthalmol.2009.125","article-title":"Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2","volume":"127","author":"Goyal","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib941","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/jop.2011.0147","article-title":"Rebamipide Increases Mucin-Like Substance Contents and Periodic Acid Schiff Reagent-Positive Cells Density in Normal Rabbits","volume":"28","author":"Urashima","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2017.05.006_bib942","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1167\/iovs.04-1344","article-title":"D-beta-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board","volume":"46","author":"Nakamura","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib943","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1755-3768.2012.02485.x","article-title":"Efficacy of a novel moist cool air device in office workers with dry eye disease","volume":"91","author":"Hirayama","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib944","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0161-6420(87)33417-7","article-title":"The treatment of aqueous-deficient dry eye with removable punctal plugs. A clinical and impression-cytologic study","volume":"94","author":"Willis","year":"1987","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib945","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00003226-199405000-00001","article-title":"Spectacle side panels and moist inserts for the treatment of dry-eye patients","volume":"13","author":"Tsubota","year":"1994","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib946","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1542-0124(12)70096-4","article-title":"Isolation of the ocular surface to treat dysfunctional tear syndrome associated with computer use","volume":"5","author":"Yee","year":"2007","journal-title":"Ocul Surf"},{"issue":"6 Suppl","key":"10.1016\/j.jtos.2017.05.006_bib947","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0004-27492008000700015","article-title":"Tearful relations: oxidative stress, inflammation and eye diseases","volume":"71","author":"Wakamatsu","year":"2008","journal-title":"Arq Bras Oftalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib948","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1395-3907.2003.00158.x","article-title":"The effects of chronic smoking on the ocular surface and tear characteristics: a clinical, histological and biochemical study","volume":"81","author":"Satici","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib949","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ajo.2005.12.047","article-title":"Smoking associated with damage to the lipid layer of the ocular surface","volume":"141","author":"Altinors","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib950","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4066\/AMJ.2012.1035","article-title":"The effect of smoking on the ocular surface and the precorneal tear film","volume":"5","author":"Thomas","year":"2012","journal-title":"Australas Med J"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib951","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/eye.2008.78","article-title":"Alterations of the tear film and ocular surface health in chronic smokers","volume":"22","author":"Matsumoto","year":"2008","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib952","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cyto.2008.05.011","article-title":"Tear cytokine and ocular surface alterations following brief passive cigarette smoke exposure","volume":"43","author":"Rummenie","year":"2008","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib953","doi-asserted-by":"crossref","first-page":"TFOS37","DOI":"10.1167\/iovs.13-13215","article-title":"The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens materials, design, and care subcommittee","volume":"54","author":"Jones","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2017.05.006_bib954","doi-asserted-by":"crossref","first-page":"TFOS98","DOI":"10.1167\/iovs.13-13187","article-title":"The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens interactions with the ocular surface and adnexa subcommittee","volume":"54","author":"Efron","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib955","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02857366","article-title":"A survey on treatment of dry eye by traditional chinese medicine and integrative chinese and Western medicine","volume":"12","author":"Zhou","year":"2006","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.jtos.2017.05.006_bib956","first-page":"1653","article-title":"Effect of yangyin yiqi huoxue recipe on immune balance of Th1\/Th2 in serum and submaxillary glands of NOD mice with Sjogren's syndrome","volume":"33","author":"Wu","year":"2013","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib957","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3892\/mmr.2014.2208","article-title":"Therapeutic effect of Zeng Ye decoction on primary Sj\u00f6gren's syndrome via upregulation of aquaporin1 and aquaporin5 expression levels","volume":"10","author":"Wu","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jtos.2017.05.006_bib958","doi-asserted-by":"crossref","first-page":"640658","DOI":"10.1155\/2012\/640658","article-title":"Chinese Herbal Medicine in Treating Primary Sj\u00f6gren's Syndrome: A Systematic Review of Randomized Trials","volume":"2012","author":"Luo","year":"2012","journal-title":"Evid Based Complement Altern Med"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib959","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ptr.1687","article-title":"Clinical evaluation of the traditional chinese prescription Chi-Ju-Di-Huang-Wan for dry eye","volume":"19","author":"Chang","year":"2005","journal-title":"Phytother Res"},{"issue":"15","key":"10.1016\/j.jtos.2017.05.006_bib960","first-page":"2721","article-title":"Traditional Chinese medicine compound ShengJinRunZaoYangXue granules for treatment of primary Sj\u00f6gren's syndrome: a randomized, double-blind, placebo-controlled clinical trial","volume":"127","author":"Hu","year":"2014","journal-title":"Chin Med J"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib961","first-page":"330","article-title":"Additive activity of royal jelly and honey against Pseudomonas aeruginosa","volume":"13","author":"Boukraa","year":"2008","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.jtos.2017.05.006_bib962","first-page":"59","article-title":"Apilak (royal jelly) in the therapy of trophic disorders of the cornea in eye burns","volume":"79","author":"Tartakovskaia","year":"1966","journal-title":"Vestn Oftalmol"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib963","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.3390\/molecules16066378","article-title":"Antioxidant capacities and total phenolic contents increase with gamma irradiation in two types of Malaysian honey","volume":"16","author":"Hussein","year":"2011","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib964","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.arcmed.2005.03.038","article-title":"Bactericidal activity of different honeys against pathogenic bacteria","volume":"36","author":"Lusby","year":"2005","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib965","doi-asserted-by":"crossref","first-page":"e106338","DOI":"10.1371\/journal.pone.0106338","article-title":"Oral administration of royal jelly restores tear secretion capacity in rat blink-suppressed dry eye model by modulating lacrimal gland function","volume":"9","author":"Imada","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib966","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.ico.0000225716.85382.7b","article-title":"Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease","volume":"25","author":"Albietz","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib967","doi-asserted-by":"crossref","first-page":"e000065","DOI":"10.1136\/bmjophth-2016-000065","article-title":"Pre-clinical development of MGO Manuka Honey microemulsion for blephar-itis management","volume":"0","author":"Craig","year":"2017","journal-title":"BMJ Open Ophth"},{"key":"10.1016\/j.jtos.2017.05.006_bib968","doi-asserted-by":"crossref","first-page":"e000066","DOI":"10.1136\/bmjophth-2016-000066","article-title":"Randomised masked trial of the clinical safety and tolerability of MGO Manuka Honey eye cream for the management of blepharitis","volume":"0","author":"Craig","year":"2017","journal-title":"BMJ Open Ophth"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib969","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5539\/gjhs.v5n4p55","article-title":"Prevalence of harmful\/traditional medication use in traumatic eye injury","volume":"5","author":"Ajite","year":"2013","journal-title":"Glob J Health Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib970","first-page":"15","article-title":"Use of Traditional Eye Medicines by corneal ulcer patients presenting to a hospital in South India","volume":"47","author":"Prajna","year":"1999","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib971","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/tropej\/fml063","article-title":"Switch from antibiotic eye drops to instillation of mother's milk drops as a treatment of infant epiphora","volume":"53","author":"Verd","year":"2007","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.jtos.2017.05.006_bib972","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/2277-9531.134776","article-title":"Evaluation of preventive effects of colostrum against neonatal conjunctivitis: A randomized clinical trial","volume":"3","author":"Ghaemi","year":"2014","journal-title":"J Educ Health Promot"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib973","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/tropej\/28.1.35","article-title":"Human colostrum for prophylaxis against sticky eyes and conjunctivitis in the newborn","volume":"28","author":"Singh","year":"1982","journal-title":"J Trop Pediatr"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib974","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/bjophthalmol-2012-302833","article-title":"Antibacterial effect of human milk for common causes of paediatric conjunctivitis","volume":"97","author":"Baynham","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2017.05.006_bib975","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/tropej\/42.6.327","article-title":"In vitro activity of human milk against the causative organisms of ophthalmia neonatorum in Benin City, Nigeria","volume":"42","author":"Ibhanesebhor","year":"1996","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.jtos.2017.05.006_bib976","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/978-1-4615-2417-5_100","article-title":"Treatment of severe eye dryness and problematic eye lesions with enriched bovine colostrum lactoserum","volume":"350","author":"Chaumeil","year":"1994","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtos.2017.05.006_bib977","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fphar.2015.00280","article-title":"Effects of Topical Fucosyl-Lactose, a Milk Oligosaccharide, on Dry Eye Model: An Example of Nutraceutical Candidate","volume":"6","author":"Bucolo","year":"2015","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.jtos.2017.05.006_bib978","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jams.2013.07.008","article-title":"Neurobiological mechanisms of acupuncture for some common illnesses: a clinician's perspective","volume":"7","author":"Cheng","year":"2014","journal-title":"J Acupunct Meridian Stud"},{"key":"10.1016\/j.jtos.2017.05.006_bib979","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1111\/j.1755-3768.2011.02201.x","article-title":"Acupuncture has effect on increasing tear break-up time: acupuncture for treating dry eye, a randomized placebo-controlled trial","volume":"90","author":"Lan","year":"2012","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2017.05.006_bib980","doi-asserted-by":"crossref","first-page":"e36638","DOI":"10.1371\/journal.pone.0036638","article-title":"Acupuncture for the treatment of dry eye: a multicenter randomised controlled trial with active comparison intervention (artificial teardrops)","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jtos.2017.05.006_bib981","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1142\/S0192415X10008123","article-title":"Clinical curative effect of acupuncture therapy on xerophthalmia","volume":"38","author":"Gong","year":"2010","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.jtos.2017.05.006_bib982","doi-asserted-by":"crossref","first-page":"143858","DOI":"10.1155\/2015\/143858","article-title":"Acupuncture therapy is more effective than artificial tears for dry eye syndrome: evidence based on a meta-analysis","volume":"2015","author":"Yang","year":"2015","journal-title":"Evid Based Complement Altern Med"},{"key":"10.1016\/j.jtos.2017.05.006_bib983","doi-asserted-by":"crossref","first-page":"492150","DOI":"10.1155\/2015\/492150","article-title":"Fourier-domain optical coherence tomography for monitoring the lower tear meniscus in dry eye after acupuncture treatment","volume":"2015","author":"Lin","year":"2015","journal-title":"Evid Based Complement Altern Med"},{"key":"10.1016\/j.jtos.2017.05.006_bib984","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/978-1-4615-5359-5_146","article-title":"Dry eye treatment with acupuncture. A prospective, randomized, double-masked study","volume":"438","author":"Nepp","year":"1998","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.jtos.2017.05.006_bib985","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1142\/S0192415X0600376X","article-title":"A clinical study of acupuncture and SSP (silver spike point) electro-therapy for dry eye syndrome","volume":"34","author":"Tseng","year":"2006","journal-title":"Am J Chin Med"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib986","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1111\/j.1755-3768.2010.02027.x","article-title":"Acupuncture for treating dry eye: a randomized placebo-controlled trial","volume":"88","author":"Shin","year":"2010","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib987","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/ICO.0000000000000464","article-title":"Depression, Stress, Quality of Life, and Dry Eye Disease in Korean Women: A Population-Based Study","volume":"34","author":"Na","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2017.05.006_bib988","doi-asserted-by":"crossref","first-page":"7954","DOI":"10.1167\/iovs.11-8050","article-title":"Association between depression and dry eye disease in an elderly population","volume":"52","author":"Kim","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib989","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02713683.2010.519850","article-title":"Anxiety and depression in patients with dry eye syndrome","volume":"36","author":"Li","year":"2011","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2017.05.006_bib990","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2147\/NDT.S81515","article-title":"High prevalence of sleep and mood disorders in dry eye patients: survey of 1,000 eye clinic visitors","volume":"11","author":"Ayaki","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.jtos.2017.05.006_bib991","series-title":"Children's Health and the Environment: A Global Perspective","author":"DeGargino","year":"2004"},{"issue":"5","key":"10.1016\/j.jtos.2017.05.006_bib992","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1037\/0003-066X.60.5.410","article-title":"Positive psychology progress: empirical validation of interventions","volume":"60","author":"Seligman","year":"2005","journal-title":"Am Psychol"},{"key":"10.1016\/j.jtos.2017.05.006_bib993","doi-asserted-by":"crossref","first-page":"e0123299","DOI":"10.1371\/journal.pone.0123299","article-title":"Associations between subjective happiness and dry eye disease: a new perspective from the Osaka study","volume":"10","author":"Kawashima","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2017.05.006_bib994","doi-asserted-by":"crossref","first-page":"943786","DOI":"10.1155\/2014\/943786","article-title":"The Association between Dry Eye Disease and Physical Activity as well as Sedentary Behavior: Results from the Osaka Study","volume":"2014","author":"Kawashima","year":"2014","journal-title":"J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib995","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1167\/iovs.13-13289","article-title":"Aerobic exercise increases tear secretion in type 2 diabetic mice","volume":"55","author":"Sano","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.jtos.2017.05.006_bib996","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1167\/iovs.03-0270","article-title":"The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity","volume":"44","author":"Begley","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib997","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0161-6420(97)30125-0","article-title":"Relation between signs and symptoms of dry eye in the elderly. A population-based perspective","volume":"104","author":"Schein","year":"1997","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.jtos.2017.05.006_bib998","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","article-title":"The lack of association between signs and symptoms in patients with dry eye disease","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2017.05.006_bib999","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/OPTH.S1496","article-title":"The challenge of dry eye diagnosis","volume":"2","author":"Savini","year":"2008","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib1000","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0008-4182(04)80071-1","article-title":"Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sj\u00f6gren's syndrome","volume":"39","author":"Adatia","year":"2004","journal-title":"Can J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2017.05.006_bib1001","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1167\/iovs.04-1426","article-title":"Decreased corneal sensitivity in patients with dry eye","volume":"46","author":"Bourcier","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.jtos.2017.05.006_bib1002","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/bjophthalmol-2013-304619","article-title":"Diagnosing the severity of dry eye: a clear and practical algorithm","volume":"98","author":"Baudouin","year":"2014","journal-title":"Br J Ophthalmol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012417301143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012417301143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T12:51:28Z","timestamp":1750769488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012417301143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":1002,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1542012417301143"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2017.05.006","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TFOS DEWS II Management and Therapy Report","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}